Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Nuclear Receptors Meta-Pathway WP2882,1.2154675803973298e-06,2.4865160280275695,33.867297443122204,"['GSTP1', 'AMIGO2', 'SLC2A1', 'IRS2', 'DBI', 'SLC2A4', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'DNAJB1', 'SRPX2', 'ZIC2', 'FTH1', 'PRDX1', 'PDK4', 'HMOX1', 'CCL2', 'STOM', 'HES1', 'JUNB', 'SLC39A1', 'SLC19A2', 'CBR3', 'NQO1', 'HSP90AA1', 'GADD45B', 'SLC10A1', 'GPX3', 'PTGES3', 'HGF', 'NRG1', 'SLC39A14', 'SOD3', 'NFKB2', 'TGFBR3', 'SLC5A9', 'SPINK13', 'ACKR3', 'ANGPTL4', 'GCLM', 'EPHA2', 'HSPA1A', 'FKBP5']",0.0006089492577790622,0,0,43
2,Hematopoietic Stem Cell Differentiation WP2849,1.8544716417109075e-05,6.619440353460972,72.12095819723139,"['HES6', 'MUC1', 'KITLG', 'SPI1', 'CSF1', 'TRIM29', 'PIM1', 'CXCR4', 'NFATC2', 'FOS', 'RUNX1']",0.004645451462485823,0,0,11
3,Complement and Coagulation Cascades WP558,3.366417003494684e-05,6.939491707703628,71.47035589879646,"['C1QB', 'CPB2', 'SERPIND1', 'F10', 'C1R', 'PROS1', 'CFI', 'SERPING1', 'CLU', 'F5']",0.005621916395836122,0,0,10
4,Zinc homeostasis WP3529,6.252031136940524e-05,5.514850270004909,53.38385579345985,"['MT2A', 'MT1A', 'MT1M', 'MT1F', 'MT1G', 'MT1X', 'SLC30A1', 'SLC39A1', 'MT3', 'SLC39A14', 'MT1E']",0.007830668999018006,0,0,11
5,NRF2 pathway WP2884,0.0002461084198988075,2.677331048606177,22.24792059153044,"['NQO1', 'HSP90AA1', 'GPX3', 'HGF', 'GSTP1', 'SLC2A1', 'NRG1', 'SLC2A4', 'SLC5A3', 'SLC39A14', 'SOD3', 'DNAJB1', 'SLC5A9', 'FTH1', 'PRDX1', 'HMOX1', 'GCLM', 'SLC39A1', 'EPHA2', 'CBR3', 'HSPA1A']",0.024660063673860512,0,0,21
6,Spinal Cord Injury WP2431,0.00034836125488010974,2.855428727258561,22.735695999556604,"['C1QB', 'IL1R1', 'GADD45A', 'BDNF', 'XYLT1', 'PLA2G5', 'TACR1', 'FOS', 'RHOC', 'ICAM1', 'GFAP', 'LGALS3', 'GJA1', 'ZFP36', 'CCL2', 'SLIT3', 'SOX9', 'VIM']",0.029088164782489163,0,0,18
7,Inflammatory Response Pathway WP453,0.0004363700429237027,14.99266862170088,115.99857626393631,"['LAMA5', 'LAMB2', 'LAMB1', 'THBS3', 'TNFRSF1A']",0.031231627357825004,0,0,5
8,Differentiation Pathway WP2848,0.0006196701298716292,5.543435256881253,40.94560483423557,"['NT5E', 'KITLG', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'FGF2', 'VEGFA']",0.03880684188321078,0,0,8
9,Glucocorticoid Receptor Pathway WP2880,0.0008242961126791483,3.2587881022615535,23.140591525660433,"['HSP90AA1', 'GADD45B', 'PTGES3', 'AMIGO2', 'NFKB2', 'TGFBR3', 'ZIC2', 'CCL2', 'STOM', 'SPINK13', 'ACKR3', 'ANGPTL4', 'SLC19A2']",0.045885816939139255,0,0,13
10,IL1 and megakaryocytes in obesity WP2865,0.0009305349450425788,7.713656849386857,53.83940354864287,"['IL1R1', 'IL18', 'CCL2', 'TIMP1', 'MYD88', 'ICAM1']",0.0466198007466332,0,0,6
11,Complement system WP2806,0.0011823118578231338,3.5423679781190827,23.876564631125195,"['LAMA5', 'F10', 'C1R', 'PROS1', 'CFI', 'F11', 'WAS', 'SERPING1', 'CD59', 'LAMB1', 'ICAM1']",0.051939910658144975,0,0,11
12,Oxidative Stress WP408,0.0012440697163627538,4.803526818515797,32.13255495614299,"['NQO1', 'GPX3', 'HMOX1', 'MT1X', 'FOS', 'SOD2', 'JUNB', 'SOD3']",0.051939910658144975,0,0,8
13,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0016527009656589898,8.994134897360704,57.610531422501325,"['CDKN1A', 'GALNT3', 'FAM20C', 'FGFR3', 'NFKB2']",0.06369255259962722,0,0,5
14,Adipogenesis WP236,0.001964201528668906,2.32013013013013,14.460604212191432,"['FZD1', 'CDKN1A', 'CEBPB', 'GADD45B', 'CEBPD', 'IRS1', 'GADD45A', 'EBF1', 'IRS2', 'SLC2A4', 'SFRP4', 'SOCS3', 'KLF7', 'KLF6', 'BMP1', 'NAMPT', 'PNPLA3', 'ID3', 'FAS']",0.0702903547045087,0,0,19
15,Lung fibrosis WP3624,0.002287832556542202,4.2377144832951545,25.765941374553908,"['MT2A', 'CEBPB', 'EGF', 'HGF', 'HMOX1', 'CCL2', 'TIMP1', 'FGF2']",0.07641360738850955,0,0,8
16,Osteoblast differentiation WP4787,0.0024588277507545755,2.398680196005917,14.411439884537474,"['FZD1', 'HES6', 'NOTCH3', 'SMAD1', 'FZD5', 'FZD7', 'WNT7B', 'FZD9', 'SMAD9', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'FGF2', 'GLI2', 'PRKCQ', 'SOX9', 'FGFR3']",0.07699204394550264,0,0,17
17,Vitamin D Receptor Pathway WP2877,0.0036114659777245536,2.367440902426908,13.313638910186441,"['CDKN1A', 'SERPINB1', 'IGFBP5', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'SLC2A4', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'S100A6', 'CD9', 'PRKCQ', 'JUNB']",0.10643202675529419,0,0,16
18,Fatty acid transporters WP5061,0.004375974616136323,6.423334729786343,34.88915201865878,"['FABP5', 'FABP7', 'ACSL6', 'DBI', 'ACSBG2']",0.12179796014912765,0,0,5
19,Globo Sphingolipid Metabolism WP1424,0.004720588798637338,4.907089975321817,26.28149917826122,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'ST6GALNAC3', 'A4GALT']",0.1244744730588056,0,0,6
20,IL-18 signaling pathway WP4754,0.005178460218293563,1.7631397728485108,9.27984104048242,"['CEBPB', 'CD81', 'HSPB8', 'RGS16', 'PLOD3', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'SOCS3', 'NFKBIZ', 'HMOX1', 'CCL2', 'TIMP1', 'TICAM2', 'IL18', 'FOS', 'TACR1', 'KLF2', 'VEGFA', 'NFKB2', 'TNFRSF1A', 'ACTA2', 'CCNA2', 'CLDN4', 'KITLG', 'FAS', 'KIFC3', 'PTPN7', 'MYD88', 'ARF6']",0.12972042846825377,0,0,30
21,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.006488017343305923,4.497798972853999,22.659003969874753,"['NQO1', 'GSTP1', 'EPHX1', 'HMOX1', 'FOS', 'GCLM']",0.1547855566188699,0,0,6
22,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.008099609815532788,2.608034260910007,12.56013492598439,"['SOCS3', 'NQO1', 'CDKN1A', 'HSPA5', 'HSPB1', 'NRG1', 'APOE', 'VIM', 'YBX3', 'ETS1', 'CARD14']",0.1764306311992142,0,0,11
23,Selenium Micronutrient Network WP15,0.008099609815532788,2.608034260910007,12.56013492598439,"['SERPINA3', 'SELENOM', 'GPX3', 'PRDX1', 'SELENOP', 'DIO2', 'CCL2', 'SOD2', 'SOD3', 'ICAM1', 'NFKB2']",0.1764306311992142,0,0,11
24,Ovarian infertility WP34,0.008690400018556477,4.151475816919691,19.70097922392161,"['CEBPB', 'DMC1', 'MSH5', 'ZP3', 'INHA', 'SYNE2']",0.1779074244807353,0,0,6
25,Differentiation of white and brown adipocyte WP2895,0.00932856313842154,4.995112414467253,23.350523531812698,"['SMAD1', 'CEBPB', 'ZIC1', 'SMAD9', 'SLC7A10']",0.1779074244807353,0,0,5
26,Phytochemical activity on NRF2 transcriptional activation WP3,0.00932856313842154,4.995112414467253,23.350523531812698,"['NQO1', 'CEBPB', 'MAF', 'HMOX1', 'GCLM']",0.1779074244807353,0,0,5
27,Vitamin B12 metabolism WP1533,0.009587825271416871,3.4991434165442974,16.261433384827548,"['SERPINA3', 'CCL2', 'APOE', 'SOD2', 'SOD3', 'ICAM1', 'NFKB2']",0.1779074244807353,0,0,7
28,Neural Crest Differentiation WP2064,0.010033531818713628,2.297501301405518,10.572693443342212,"['NOTCH3', 'SMAD1', 'TBX6', 'ETS1', 'FGF2', 'GFAP', 'NFKB2', 'DCT', 'ZIC1', 'HES1', 'SOX9', 'FGFR3', 'HES5']",0.17952855147055455,0,0,13
29,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.010837882240655908,1.6263141529333658,7.358596117232464,"['PFKFB1', 'LAMA5', 'CDKN1A', 'CSF1', 'LAMA2', 'CAB39L', 'IRS1', 'TNC', 'SLC2A1', 'PIK3CD', 'IRS2', 'SLC2A4', 'PIK3C2A', 'FGF2', 'IGF1R', 'THBS3', 'IFNAR2', 'HSP90AA1', 'ANGPT2', 'EGF', 'LAMB2', 'HGF', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL5A1', 'COL6A2', 'IL3RA', 'FGFR3', 'EPHA2']",0.1872337587092624,0,0,32
30,Genotoxicity pathway WP4286,0.012177108247539335,2.572900241774414,11.341852318313098,"['ACTA2', 'ITPKC', 'PLK3', 'CDKN1A', 'DAAM1', 'CEBPD', 'GADD45A', 'ID2', 'AEN', 'TRIM22']",0.20335770773390688,0,0,10
31,Development and heterogeneity of the ILC family WP3893,0.012918185623906888,5.991208791208791,26.056481317312517,"['NFIL3', 'IL7', 'ID2', 'IL18']",0.2087745483089468,0,0,4
32,Endochondral Ossification with Skeletal Dysplasias WP4808,0.015685355404092268,2.6133301707779886,10.858459454613103,"['ADAMTS1', 'COL10A1', 'SOX9', 'FGF2', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.23547055713096013,0,0,9
33,Endochondral Ossification WP474,0.015685355404092268,2.6133301707779886,10.858459454613103,"['ADAMTS1', 'COL10A1', 'SOX9', 'FGF2', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.23547055713096013,0,0,9
34,Blood Clotting Cascade WP272,0.015980037809286717,8.98243045387994,37.155059819846606,"['F10', 'F11', 'F5']",0.23547055713096013,0,0,3
35,Type II interferon signaling (IFNG) WP619,0.01842039107882655,3.372248716067498,13.469762987756255,"['SOCS3', 'SPI1', 'TAP1', 'GBP1', 'ICAM1', 'PSMB9']",0.25205878538145404,0,0,6
36,Breast cancer pathway WP4262,0.018449857743186197,1.804148148148148,7.203419819441322,"['FZD1', 'NOTCH3', 'CDKN1A', 'GADD45B', 'FZD5', 'GADD45A', 'EGF', 'FZD7', 'WNT7B', 'FZD9', 'PIK3CD', 'WNT7A', 'FOS', 'FGF2', 'IGF1R', 'NFKB2', 'SFRP4', 'HES1', 'HES5']",0.25205878538145404,0,0,19
37,Ferroptosis WP4313,0.020231993979407076,2.6660135521267043,10.39875937907017,"['STEAP3', 'FTH1', 'ACSL6', 'HMOX1', 'GCLM', 'SAT1', 'CP', 'SLC39A14']",0.25205878538145404,0,0,8
38,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.021769563829413842,2.308258334748401,8.834264259693411,"['CDKN1A', 'CEBPB', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'HES5']",0.25205878538145404,0,0,10
39,Alpha 6 Beta 4 signaling pathway WP244,0.02187006092465413,2.8620010679482046,10.940390199100973,"['LAMA5', 'LAMA2', 'IRS1', 'LAMB2', 'GAB1', 'IRS2', 'LAMB1']",0.25205878538145404,0,0,7
40,Transcription factor regulation in adipogenesis WP3599,0.022375497951325908,3.74541788856305,14.231796795442328,"['CEBPB', 'CEBPD', 'IRS1', 'IRS2', 'SLC2A4']",0.25205878538145404,0,0,5
41,Prostaglandin Synthesis and Regulation WP98,0.022860372712694223,3.173622200163998,11.991056444777564,"['HSD11B1', 'EDNRA', 'ANXA2', 'S100A6', 'SOX9', 'S100A10']",0.25205878538145404,0,0,6
42,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.022860372712694223,3.173622200163998,11.991056444777564,"['FZD1', 'BMP1', 'P3H2', 'TNFRSF11B', 'PLOD1', 'COLGALT1']",0.25205878538145404,0,0,6
43,ESC Pluripotency Pathways WP3931,0.02330457548532153,1.9039049659849794,7.156979752729159,"['FZD1', 'SMAD1', 'FZD5', 'EGF', 'FZD7', 'WNT7B', 'FZD9', 'GAB1', 'SMAD9', 'PIK3CD', 'WNT7A', 'FOS', 'FGF2', 'SELENOP', 'FGFR3']",0.25205878538145404,0,0,15
44,"GPCRs, Class A Rhodopsin-like WP455",0.023926901559213717,2.078283544016779,7.757716774496312,"['P2RY12', 'GPR39', 'EDNRA', 'GPR37', 'HTR1E', 'GPR87', 'CHRM5', 'HTR2B', 'ACKR4', 'CXCR4', 'ACKR3', 'GPR19']",0.25205878538145404,0,0,12
45,Exercise-induced Circadian Regulation WP410,0.024672849357727705,2.3821583044982697,8.818873572967796,"['DNAJA1', 'HSPA8', 'CEBPB', 'BTG1', 'RBPMS', 'PPP1R3C', 'GSTP1', 'TAB2', 'ETV6']",0.25205878538145404,0,0,9
46,Galanin receptor pathway WP4970,0.02587857231480182,4.492673992673993,16.417758172588687,"['CDKN1A', 'FOS', 'SLC2A4', 'VEGFA']",0.25205878538145404,0,0,4
47,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.025898855803309563,6.736273792093704,24.611356822971814,"['SPI1', 'APOE', 'NFKB2']",0.25205878538145404,0,0,3
48,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.025898855803309563,6.736273792093704,24.611356822971814,"['SPI1', 'CSF1', 'ID2']",0.25205878538145404,0,0,3
49,Farnesoid X receptor pathway WP2879,0.025898855803309563,6.736273792093704,24.611356822971814,"['SLC10A1', 'IRS2', 'FKBP5']",0.25205878538145404,0,0,3
50,Gene regulatory network modelling somitogenesis  WP2854,0.025898855803309563,6.736273792093704,24.611356822971814,"['LFNG', 'HES1', 'TBX6']",0.25205878538145404,0,0,3
51,Folate Metabolism WP176,0.027773332484081904,2.4817451670931616,8.893777993583395,"['SERPINA3', 'CSF1', 'GPX3', 'CCL2', 'SOD2', 'SOD3', 'ICAM1', 'NFKB2']",0.25205878538145404,0,0,8
52,Benzene metabolism WP3891,0.028174235491739377,17.954645208485736,64.0863653615607,"['NQO1', 'EPHX1']",0.25205878538145404,0,0,2
53,COVID-19 adverse outcome pathway WP4891,0.028174235491739377,17.954645208485736,64.0863653615607,"['IL7', 'CCL2']",0.25205878538145404,0,0,2
54,Drug Induction of Bile Acid Pathway WP2289,0.028174235491739377,17.954645208485736,64.0863653615607,"['SLC10A1', 'SLC51A']",0.25205878538145404,0,0,2
55,EV release from cardiac cells and their functional effects WP3297,0.028174235491739377,17.954645208485736,64.0863653615607,"['RGS16', 'KLF2']",0.25205878538145404,0,0,2
56,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.028174235491739377,17.954645208485736,64.0863653615607,"['NRP1', 'VEGFA']",0.25205878538145404,0,0,2
57,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.034478226845156036,3.993162393162393,13.446683896795143,"['CD63', 'EGF', 'CD81', 'HSPB1']",0.2978205456797099,0,0,4
58,Hypertrophy Model WP516,0.034478226845156036,3.993162393162393,13.446683896795143,"['IL1R1', 'IFRD1', 'IL18', 'VEGFA']",0.2978205456797099,0,0,4
59,IL-4 signaling pathway WP395,0.036815993682516285,2.1884737678855326,7.225952840682135,"['SOCS3', 'CEBPB', 'NFIL3', 'IRS1', 'INPP5D', 'PIK3CD', 'FLNA', 'IRS2', 'FOS']",0.3126239463549264,0,0,9
60,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.03839403309968451,5.388579795021962,17.56597919328906,"['SMAD1', 'SST', 'SMAD9']",0.31533459972035965,0,0,3
61,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.03839403309968451,5.388579795021962,17.56597919328906,"['EGF', 'TIMP1', 'VIM']",0.31533459972035965,0,0,3
62,Vitamin A and carotenoid metabolism WP716,0.04029787560173706,2.6969185619955978,8.661036716054607,"['RBP2', 'RBP1', 'BCO2', 'BCO1', 'RLBP1', 'RPE65']",0.3256328334914559,0,0,6
63,Copper homeostasis WP3286,0.04163684700648449,2.1307082043343653,6.773030803929177,"['STEAP3', 'MT2A', 'MT1A', 'MT1F', 'MT1G', 'MT1X', 'SOD3', 'MT3', 'MT1E']",0.3259384429726364,0,0,9
64,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.04163684700648449,2.1307082043343653,6.773030803929177,"['IL1R1', 'IRAK2', 'MKNK2', 'IRF7', 'TAB2', 'IL1RAP', 'FOS', 'MAP3K14', 'MYD88']",0.3259384429726364,0,0,9
65,Striated Muscle Contraction Pathway WP383,0.043614538059462846,2.995601173020528,9.383315496888315,"['ACTA2', 'TNNT1', 'TCAP', 'VIM', 'TTN']",0.3361674395044752,0,0,5
66,Cori Cycle WP1946,0.04453810620270354,3.5935531135531136,11.181017585645076,"['SLC2A1', 'GPT', 'SLC2A4', 'PFKP']",0.3380847152659769,0,0,4
67,Wnt signaling in kidney disease WP4150,0.0475715172686935,2.5682842469342835,7.821763796909152,"['FZD1', 'FZD5', 'WNT7B', 'FZD7', 'FZD9', 'WNT7A']",0.35572134554649915,0,0,6
68,Transcriptional cascade regulating adipogenesis WP4211,0.05338507967874927,4.490117130307467,13.157048882947828,"['CEBPB', 'CEBPD', 'KLF2']",0.3933224252801968,0,0,3
69,Phosphodiesterases in neuronal function WP4222,0.05456393825339591,2.1159182262177465,6.153898664547669,"['PDE10A', 'CHRNA7', 'PDE6C', 'PDE5A', 'ADCY2', 'PDE6B', 'PDE8B', 'GRIN2D']",0.39618163862248335,0,0,8
70,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.056059179574871394,3.2666000666000667,9.41220950460264,"['ICAM1', 'NFKB2', 'VEGFA', 'TNFRSF1A']",0.40122355667157955,0,0,4
71,DNA damage response WP707,0.05858513429874928,1.9743185078909613,5.601683153549846,"['CCNB3', 'CDKN1A', 'CCNE2', 'GADD45B', 'GADD45A', 'SESN1', 'CHEK2', 'FAS', 'PML']",0.4080117568138185,0,0,9
72,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.05863642014090805,1.7703468354736218,5.021410474159654,"['MRAS', 'EGF', 'HGF', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1', 'GAS6', 'FGF2', 'FGFR3', 'IGF1R', 'VEGFA']",0.4080117568138185,0,0,12
73,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.06126183233862758,1.8740802060338484,5.233553135918099,"['TUBA1C', 'HSPA8', 'TUBB2B', 'TUBA1A', 'GPR37', 'HSPA5', 'RNF19A', 'HSPA2', 'HSPA1B', 'HSPA1A']",0.41808877824376456,0,0,10
74,NRF2-ARE regulation WP4357,0.0627551975009763,2.642746248059341,7.316479657705167,"['NQO1', 'CEBPB', 'MAF', 'HMOX1', 'GCLM']",0.41808877824376456,0,0,5
75,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.0627551975009763,2.642746248059341,7.316479657705167,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.41808877824376456,0,0,5
76,Neovascularisation processes WP4331,0.06440492732883253,2.344572394653737,6.4301425118786115,"['NOTCH3', 'SMAD1', 'KITLG', 'CXCR4', 'SMAD9', 'NFKB2']",0.41808877824376456,0,0,6
77,Proximal tubule transport WP4917,0.06440492732883253,2.344572394653737,6.4301425118786115,"['SLC13A3', 'SLC22A6', 'SLC1A1', 'SLC2A1', 'SLC3A1', 'SLC4A2']",0.41808877824376456,0,0,6
78,p53 transcriptional gene network WP4963,0.0650916660738795,1.9271533613445377,5.264903498255577,"['CDKN1A', 'GADD45A', 'SESN1', 'SLC2A1', 'CCL2', 'FAS', 'SAT1', 'PML', 'ICAM1']",0.41808877824376456,0,0,9
79,Pregnane X receptor pathway WP2876,0.06901796171749515,2.994139194139194,8.004497269592727,"['HSP90AA1', 'SRPX2', 'CYP3A5', 'CYP3A7']",0.4376961876008237,0,0,4
80,Eicosanoid Synthesis WP167,0.07072805425112598,3.848358084082828,10.193965672302662,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.44293443974767643,0,0,3
81,miRNA regulation of DNA damage response WP1530,0.07203650095800794,1.8821819425444597,4.951234561174204,"['CCNB3', 'CDKN1A', 'CCNE2', 'GADD45B', 'GADD45A', 'SESN1', 'CHEK2', 'FAS', 'PML']",0.4455590985180491,0,0,9
82,miRNAs involvement in the immune response in sepsis WP4329,0.07383710212291048,2.4957233626588464,6.503590373975095,"['IRF7', 'TAB2', 'MYD88', 'ICAM1', 'NFKB2']",0.44664929403486225,0,0,5
83,MECP2 and Associated Rett Syndrome WP3584,0.07399579122733248,1.798822663723326,4.683679226990942,"['CSRP1', 'CEBPD', 'BCL6', 'BDNF', 'SST', 'TAP1', 'FGF2', 'IGF1R', 'FKBP5', 'GRIA4']",0.44664929403486225,0,0,10
84,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.08085984877177194,2.029605418975889,5.104534520364119,"['CCNA2', 'CDKN1A', 'HSP90AA1', 'FAS', 'FOS', 'JUNB', 'TNFRSF1A']",0.4613006361193647,0,0,7
85,miR-517 relationship with ARCN1 and USP1 WP3596,0.08194118858312245,5.98390636430139,14.970258699172243,"['CDKN1A', 'ID2']",0.4613006361193647,0,0,2
86,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.08336950066250458,2.7635953789799945,6.866077372389701,"['TGFBR3', 'ANGPT2', 'FLNA', 'ENG']",0.4613006361193647,0,0,4
87,Microglia Pathogen Phagocytosis Pathway WP3937,0.08336950066250458,2.7635953789799945,6.866077372389701,"['C1QB', 'PLCG2', 'PIK3CD', 'PIK3C2A']",0.4613006361193647,0,0,4
88,The influence of laminopathies on Wnt signaling WP4844,0.08430698514838772,2.156654438738078,5.334033057631873,"['CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'SLC2A4', 'HES5']",0.4613006361193647,0,0,6
89,Aryl Hydrocarbon Receptor Pathway WP2873,0.08590848036538613,2.364176570458404,5.802806923861064,"['NQO1', 'HSP90AA1', 'PTGES3', 'HES1', 'JUNB']",0.4613006361193647,0,0,5
90,TYROBP causal network in microglia WP3945,0.08590848036538613,2.364176570458404,5.802806923861064,"['MAF', 'IGSF6', 'IL18', 'PPP1R18', 'IL13RA1']",0.4613006361193647,0,0,5
91,PI3K-Akt signaling pathway WP4172,0.08705013856209243,1.3568593490654544,3.312461408468503,"['LAMA5', 'CDKN1A', 'CSF1', 'LAMA2', 'IRS1', 'TNC', 'PIK3CD', 'FGF2', 'IGF1R', 'THBS3', 'IFNAR2', 'HSP90AA1', 'ANGPT2', 'BDNF', 'EGF', 'LAMB2', 'HGF', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'CCNE2', 'IL7', 'COL6A2', 'IL3RA', 'FGFR3', 'EPHA2']",0.4613006361193647,0,0,28
92,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.09023445576785977,3.3670387994143485,8.098886344516949,"['TNC', 'CXCR4', 'VEGFA']",0.4613006361193647,0,0,3
93,ID signaling pathway WP53,0.09023445576785977,3.3670387994143485,8.098886344516949,"['PAX8', 'ID2', 'ID3']",0.4613006361193647,0,0,3
94,Kynurenine Pathway and links to Cellular Senescence WP5044,0.09023445576785977,3.3670387994143485,8.098886344516949,"['CDKN1A', 'AADAT', 'HAAO']",0.4613006361193647,0,0,3
95,Leptin Insulin Overlap WP3935,0.09023445576785977,3.3670387994143485,8.098886344516949,"['SOCS3', 'IRS1', 'IRS2']",0.4613006361193647,0,0,3
96,miR-509-3p alteration of YAP1/ECM axis WP3967,0.09023445576785977,3.3670387994143485,8.098886344516949,"['EDNRA', 'COL5A1', 'TEAD3']",0.4613006361193647,0,0,3
97,NOTCH1 regulation of endothelial cell calcification WP3413,0.09023445576785977,3.3670387994143485,8.098886344516949,"['SAT1', 'FGFR3', 'VEGFA']",0.4613006361193647,0,0,3
98,Tryptophan catabolism leading to NAD+ production WP4210,0.09023445576785977,3.3670387994143485,8.098886344516949,"['AADAT', 'HAAO', 'NAMPT']",0.4613006361193647,0,0,3
99,Signal transduction through IL1R WP4496,0.09894323181165388,2.2457844574780057,5.194968840112723,"['IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14', 'MYD88']",0.5007127185620059,0,0,5
100,Aryl Hydrocarbon Receptor Netpath WP2586,0.10721699295728332,1.9965761799951087,4.45815600353891,"['NQO1', 'CDKN1A', 'HSP90AA1', 'KLF6', 'PSRC1', 'VEGFA']",0.5318387472435538,0,0,6
101,Glycolysis and Gluconeogenesis WP534,0.10721699295728332,1.9965761799951087,4.45815600353891,"['PGAM2', 'SLC2A1', 'SLC2A4', 'HK2', 'GCK', 'PFKP']",0.5318387472435538,0,0,6
102,Cytokines and Inflammatory Response WP530,0.1149217942168367,4.487564008778347,9.708860135417137,"['CSF1', 'IL7']",0.54818082410953,0,0,2
103,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.1149217942168367,4.487564008778347,9.708860135417137,"['SOCS3', 'CHI3L1']",0.54818082410953,0,0,2
104,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.1149217942168367,4.487564008778347,9.708860135417137,"['LFNG', 'TBX6']",0.54818082410953,0,0,2
105,Cardiac Progenitor Differentiation WP2406,0.1159823699712778,2.3947252747252747,5.158997567073727,"['BMP1', 'CXCR4', 'NRG1', 'FGF2']",0.54818082410953,0,0,4
106,Peptide GPCRs WP24,0.1159823699712778,2.3947252747252747,5.158997567073727,"['EDNRA', 'GNRHR', 'CXCR4', 'TACR1']",0.54818082410953,0,0,4
107,MAPK Signaling Pathway WP382,0.1201679243992755,1.3242953431372548,2.806003243480452,"['CACNA1A', 'HSPB1', 'FGF2', 'MKNK2', 'FLNA', 'FLNB', 'MAP3K6', 'HSPA8', 'IL1R1', 'GADD45A', 'BDNF', 'EGF', 'CACNA2D3', 'FOS', 'HSPA2', 'NFKB2', 'TNFRSF1A', 'MRAS', 'FAS', 'TAB2', 'PTPN7', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.5626554217199722,0,0,25
108,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.12143470326373565,1.605303269210554,3.384587030999206,"['FZD1', 'SFRP4', 'SFRP2', 'FZD5', 'H2AFY2', 'WIF1', 'WNT7B', 'FZD7', 'FZD9', 'WNT7A']",0.5633220956956626,0,0,10
109,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.12294643317004539,1.6509003601440577,3.4602979206326654,"['FZD1', 'SFRP4', 'SFRP2', 'FZD5', 'WIF1', 'WNT7B', 'FZD7', 'FZD9', 'WNT7A']",0.5651024130109426,0,0,9
110,Sleep regulation WP3591,0.13407433596889143,2.244871794871795,4.5107575805170494,"['CST3', 'IL18', 'GHRL', 'FOS']",0.6106476574583146,0,0,4
111,IL-1 signaling pathway WP195,0.14578979868128714,1.633691804154699,3.145819669545988,"['IL1R1', 'IRAK2', 'HSPB2', 'CCL2', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88']",0.6396151946394023,0,0,8
112,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.14578979868128714,1.633691804154699,3.145819669545988,"['IFI27L2', 'PLCG2', 'PLCE1', 'CCL2', 'PRKCQ', 'ETS1', 'TNFRSF1A', 'NFKB2']",0.6396151946394023,0,0,8
113,Biogenic Amine Synthesis WP550,0.15053099098472106,3.589758595464521,6.797517681700929,"['PNMT', 'PAH']",0.6396151946394023,0,0,2
114,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.15053099098472106,3.589758595464521,6.797517681700929,"['HES1', 'VEGFA']",0.6396151946394023,0,0,2
115,Nephrogenesis WP5052,0.15053099098472106,3.589758595464521,6.797517681700929,"['GREB1L', 'RSPO3']",0.6396151946394023,0,0,2
116,Platelet-mediated interactions with vascular and circulating cells WP4462,0.15053099098472106,3.589758595464521,6.797517681700929,"['CCL2', 'ICAM1']",0.6396151946394023,0,0,2
117,Selective expression of chemokine receptors during T-cell polarization WP4494,0.15053099098472106,3.589758595464521,6.797517681700929,"['CXCR4', 'IL12RB2']",0.6396151946394023,0,0,2
118,Wnt signaling WP428,0.15064789015458976,1.4577864526280149,2.7593128022977007,"['FZD1', 'SFRP4', 'SFRP2', 'DAAM1', 'FZD5', 'DAAM2', 'WIF1', 'FZD7', 'WNT7B', 'FZD9', 'NFATC2', 'WNT7A']",0.6396151946394023,0,0,12
119,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.1532261633378482,2.112648136177548,3.962990423328495,"['TICAM2', 'IRAK2', 'CCL2', 'MYD88']",0.6450950238005205,0,0,4
120,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.1575884005253732,1.5972569189321577,2.951361348638542,"['LAMA5', 'CDKN1A', 'CD151', 'LAMB2', 'PLCE1', 'MYH9', 'VIM', 'AGRN']",0.6520455867248142,0,0,8
121,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.15947913341126338,2.448156528683615,4.494429043872885,"['FZD1', 'SFRP4', 'FZD7']",0.6520455867248142,0,0,3
122,Type II diabetes mellitus WP1584,0.15947913341126338,2.448156528683615,4.494429043872885,"['IRS1', 'CACNA1A', 'SLC2A4']",0.6520455867248142,0,0,3
123,Phosphoinositides metabolism WP4971,0.16021299963798352,1.6547839863977123,3.030324997563234,"['MTMR11', 'INPP5D', 'PLCG2', 'PIK3CD', 'PIP4K2A', 'PLCE1', 'PIK3C2A']",0.6520455867248142,0,0,7
124,TGF-beta Receptor Signaling WP560,0.16138453643488415,1.7383854400870944,3.1707547845252586,"['TGFBR3', 'SMAD1', 'EGF', 'SMAD9', 'FOS', 'ENG']",0.6520455867248142,0,0,6
125,Ebola Virus Pathway on Host WP4217,0.1721970454856289,1.391145174884113,2.4471855192695497,"['ACTN1', 'PIK3CD', 'RHOC', 'IGF1R', 'NFKB2', 'BST2', 'SOCS3', 'NEDD4', 'TYRO3', 'IRF7', 'FLNA', 'FLNB', 'GAS6']",0.683769643115949,0,0,13
126,TLR4 Signaling and Tolerance WP3851,0.17333082769605893,1.9951159951159951,3.4965469451120272,"['INPP5D', 'IRF7', 'TAB2', 'MYD88']",0.683769643115949,0,0,4
127,Toll-like Receptor Signaling related to MyD88 WP3858,0.17333082769605893,1.9951159951159951,3.4965469451120272,"['TICAM2', 'IRF7', 'MYD88', 'NFKB2']",0.683769643115949,0,0,4
128,Notch Signaling WP268,0.1764829182248538,1.6839233308877477,2.9208175354371417,"['LFNG', 'NOTCH3', 'NUMBL', 'DTX3L', 'HES1', 'HES5']",0.6907651721144668,0,0,6
129,Monoamine GPCRs WP58,0.18533412895413,2.2439604685212298,3.7824085021594183,"['HTR1E', 'CHRM5', 'HTR2B']",0.6971560511333089,0,0,3
130,NAD+ metabolism WP3644,0.18533412895413,2.2439604685212298,3.7824085021594183,"['NT5E', 'NAMPT', 'CD38']",0.6971560511333089,0,0,3
131,Biomarkers for urea cycle disorders WP4583,0.18790999085408264,2.9912216532553035,5.000701036916899,"['F10', 'GPT']",0.6971560511333089,0,0,2
132,Complement Activation WP545,0.18790999085408264,2.9912216532553035,5.000701036916899,"['C1QB', 'C1R']",0.6971560511333089,0,0,2
133,Insulin signaling in adipocytes (diabetic condition) WP3635,0.18790999085408264,2.9912216532553035,5.000701036916899,"['IRS1', 'SLC2A4']",0.6971560511333089,0,0,2
134,Insulin signaling in adipocytes (normal condition) WP3634,0.18790999085408264,2.9912216532553035,5.000701036916899,"['IRS1', 'SLC2A4']",0.6971560511333089,0,0,2
135,Aflatoxin B1 metabolism WP699,0.19063947905242182,8.970760233918128,14.867879463801472,['EPHX1'],0.6971560511333089,0,0,1
136,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.19063947905242182,8.970760233918128,14.867879463801472,['FAS'],0.6971560511333089,0,0,1
137,SCFA and skeletal muscle substrate metabolism WP4030,0.19063947905242182,8.970760233918128,14.867879463801472,['SLC2A4'],0.6971560511333089,0,0,1
138,Type 2 papillary renal cell carcinoma WP4241,0.1949356013976256,1.726680577487029,2.823271280516341,"['CDKN1A', 'EGLN3', 'SLC2A1', 'COL21A1', 'VEGFA']",0.7046693865008132,0,0,5
139,Oncostatin M Signaling Pathway WP2374,0.19550707529663283,1.497060984570169,2.4434411245229914,"['SOCS3', 'CEBPB', 'IRS1', 'CCL2', 'FOS', 'OSMR', 'JUNB', 'VEGFA']",0.7046693865008132,0,0,8
140,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.21155367657899696,1.3105627306273062,2.0356663210396855,"['RYR2', 'CEBPB', 'CHRNA4', 'BDNF', 'CHRNA7', 'TACR1', 'GCK', 'NFKB2', 'VEGFA', 'GJA1', 'SST', 'PAH', 'HES1', 'HES5']",0.746146422582683,0,0,14
141,miRNA targets in ECM and membrane receptors WP2911,0.21217632599871283,2.0711791868453653,3.211027018570873,"['COL5A1', 'LAMB2', 'COL6A2']",0.746146422582683,0,0,3
142,CAMKK2  Pathway WP4874,0.21336934315820588,1.662593678722711,2.568259346662384,"['MAF', 'WFS1', 'HMOX1', 'NFATC2', 'ICAM1']",0.746146422582683,0,0,5
143,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.21336934315820588,1.662593678722711,2.568259346662384,"['IGFBP5', 'IRS1', 'FBXO32', 'IGF1R', 'TNFRSF1A']",0.746146422582683,0,0,5
144,16p11.2 distal deletion syndrome WP4950,0.21595056142612581,1.7953113553113553,2.751684090793925,"['PLN', 'CD81', 'NFATC2', 'ATP2A1']",0.746146422582683,0,0,4
145,White fat cell differentiation WP4149,0.21595056142612581,1.7953113553113553,2.751684090793925,"['CEBPB', 'CEBPD', 'EBF1', 'KLF2']",0.746146422582683,0,0,4
146,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.22487787575998947,1.539209726443769,2.296805365280145,"['TGFBR3', 'SMAD1', 'EGF', 'SMAD9', 'FOS', 'ENG']",0.7514442225000217,0,0,6
147,Dopamine metabolism WP2436,0.2263456873625818,2.5636952659630055,3.808861183653093,"['NQO1', 'MAOB']",0.7514442225000217,0,0,2
148,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.2263456873625818,2.5636952659630055,3.808861183653093,"['ANXA2', 'APOE']",0.7514442225000217,0,0,2
149,Serotonin and anxiety-related events WP3944,0.2263456873625818,2.5636952659630055,3.808861183653093,"['FOS', 'GRIN2D']",0.7514442225000217,0,0,2
150,Thiamine metabolic pathways WP4297,0.2263456873625818,2.5636952659630055,3.808861183653093,"['SLC19A3', 'SLC19A2']",0.7514442225000217,0,0,2
151,Apoptosis Modulation and Signaling WP1772,0.22648318881737184,1.393699290060852,2.0697612946812463,"['IL1R1', 'BAG3', 'FAS', 'TNFRSF11B', 'FOS', 'MAP3K14', 'MYD88', 'TNFRSF1A', 'HSPA1A']",0.7514442225000217,0,0,9
152,Allograft Rejection WP2328,0.23232512093500807,1.6030844155844155,2.3398900749740825,"['C1QB', 'COL5A1', 'FAS', 'VIM', 'VEGFA']",0.7651507848069045,0,0,5
153,Endometrial cancer WP4155,0.23674751062357743,1.4086528071919437,2.0295321141421483,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'FOS', 'FGF2', 'FGFR3']",0.7651507848069045,0,0,8
154,Angiogenesis WP1539,0.23977779084767264,1.9230809454089102,2.746241620969177,"['SMAD1', 'FGF2', 'VEGFA']",0.7651507848069045,0,0,3
155,Apoptosis Modulation by HSP70 WP384,0.23977779084767264,1.9230809454089102,2.746241620969177,"['FAS', 'TNFRSF1A', 'HSPA1A']",0.7651507848069045,0,0,3
156,Monoamine Transport WP727,0.23977779084767264,1.9230809454089102,2.746241620969177,"['IL1R1', 'TNFRSF11B', 'FBXO32']",0.7651507848069045,0,0,3
157,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.23977779084767264,1.9230809454089102,2.746241620969177,"['SOX9', 'FGF2', 'GLI2']",0.7651507848069045,0,0,3
158,Wnt signaling pathway and pluripotency WP399,0.24132516209755958,1.340537928459249,1.9057221707918939,"['FZD1', 'FZD5', 'FZD7', 'WNT7B', 'ESRRB', 'FZD9', 'WNT7A', 'PRKCQ', 'ZBTB33', 'CD44']",0.7652145962713757,0,0,10
159,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2517335397125411,1.5476792395591061,2.1348441860006506,"['IFITM3', 'BST2', 'IFITM2', 'FOS', 'JUNB']",0.7931981345659314,0,0,5
160,One-carbon metabolism and related pathways WP3940,0.2592720630182359,1.455771251809403,1.9651126137455877,"['BHMT', 'GPX3', 'CHDH', 'SOD2', 'GCLM', 'SOD3']",0.8118456473258512,0,0,6
161,Oxidation by Cytochrome P450 WP43,0.2610251737743692,1.631834831834832,2.1917800660013684,"['CYP39A1', 'CYP4F3', 'CYP3A5', 'CYP3A7']",0.8122584600059563,0,0,4
162,Notch Signaling Pathway Netpath WP61,0.2635160225209161,1.3965736661771904,1.862528049215652,"['PSENEN', 'HES6', 'NOTCH3', 'CDKN1A', 'NUMBL', 'HES1', 'HES5']",0.814947699277648,0,0,7
163,Iron metabolism in placenta WP2007,0.2652500978966579,2.243050475493782,2.976712208132643,"['STEAP3', 'FTH1']",0.8152779082590528,0,0,2
164,Ebstein-Barr virus LMP1 signaling WP262,0.26792325123797467,1.7947291361639823,2.363756471762564,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.8184728589647884,0,0,3
165,Hypothetical Craniofacial Development Pathway WP3655,0.2718721128633191,4.4850146198830405,5.841388423300931,['ARHGAP29'],0.8205296900272461,0,0,1
166,Metabolism of alpha-linolenic acid WP4586,0.2718721128633191,4.4850146198830405,5.841388423300931,['ALOX12'],0.8205296900272461,0,0,1
167,IL17 signaling pathway WP2112,0.28420254764768993,1.560758082497213,1.9635399539737142,"['CEBPB', 'CEBPD', 'MAP3K14', 'IL17RB']",0.8469976306984066,0,0,4
168,PPAR signaling pathway WP3942,0.2949287271075629,1.3808905694452283,1.6860971501930935,"['FABP5', 'FABP7', 'ACSL6', 'DBI', 'ANGPTL4', 'ACSBG2']",0.8469976306984066,0,0,6
169,Genes controlling nephrogenesis WP4823,0.2964121644826794,1.6824213030746706,2.045831615732038,"['LAMB2', 'CXCR4', 'VEGFA']",0.8469976306984066,0,0,3
170,PKC-gamma calcium signaling pathway in ataxia WP4760,0.2964121644826794,1.6824213030746706,2.045831615732038,"['GNA14', 'CACNA1A', 'GRIA4']",0.8469976306984066,0,0,3
171,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.2964121644826794,1.6824213030746706,2.045831615732038,"['IFNAR2', 'IRF7', 'MYD88']",0.8469976306984066,0,0,3
172,Glutathione metabolism WP100,0.3041424606192476,1.9936600829066082,2.372971989968562,"['GPX3', 'GCLM']",0.8469976306984066,0,0,2
173,"GPCRs, Class B Secretin-like WP334",0.3041424606192476,1.9936600829066082,2.372971989968562,"['CALCRL', 'ADGRG2']",0.8469976306984066,0,0,2
174,GPR40 Pathway WP3958,0.3041424606192476,1.9936600829066082,2.372971989968562,"['PLCG2', 'PLCE1']",0.8469976306984066,0,0,2
175,Matrix Metalloproteinases WP129,0.3041424606192476,1.9936600829066082,2.372971989968562,"['MMP15', 'TIMP1']",0.8469976306984066,0,0,2
176,Nicotine Activity on Dopaminergic Neurons WP1602,0.3041424606192476,1.9936600829066082,2.372971989968562,"['CHRNA4', 'ADCY2']",0.8469976306984066,0,0,2
177,Regulation of toll-like receptor signaling pathway WP1449,0.3198513656167559,1.2297519328273208,1.4017928429652091,"['IFNAR2', 'TICAM2', 'IRAK2', 'SFTPD', 'IRF7', 'PIK3CD', 'TAB2', 'FOS', 'MYD88', 'NFKB2']",0.8469976306984066,0,0,10
178,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.3250600127089212,1.58332615623116,1.7792555785131146,"['FZD1', 'LAMA5', 'GLI2']",0.8469976306984066,0,0,3
179,Immune response to tuberculosis WP4197,0.3250600127089212,1.58332615623116,1.7792555785131146,"['IFNAR2', 'TAP1', 'IFI35']",0.8469976306984066,0,0,3
180,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3250600127089212,1.58332615623116,1.7792555785131146,"['NAMPT', 'SLC2A1', 'SLC2A4']",0.8469976306984066,0,0,3
181,Development of ureteric collection system WP5053,0.331304061413861,1.4356630036630036,1.5860037824490845,"['SMAD1', 'GREB1L', 'FREM1', 'GLI2']",0.8469976306984066,0,0,4
182,Interferon type I signaling pathways WP585,0.33146444508771183,1.3133153195068268,1.4502083869066134,"['IFNAR2', 'SOCS3', 'IRS1', 'PDCD4', 'PIK3CD', 'IRS2']",0.8469976306984066,0,0,6
183,IL-3 signaling pathway WP286,0.332511063036838,1.3596374300186618,1.4970725007884118,"['INPP5D', 'IL3RA', 'PIK3CD', 'ENPP3', 'FOS']",0.8469976306984066,0,0,5
184,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.332511063036838,1.3596374300186618,1.4970725007884118,"['IFNAR2', 'CD160', 'CXCL17', 'IRF7', 'CCL2']",0.8469976306984066,0,0,5
185,Male infertility WP4673,0.33348304437112675,1.2130342262792595,1.332109616037068,"['NANOS1', 'NQO1', 'BHMT', 'MSH5', 'XRCC3', 'PON1', 'FAS', 'SOD2', 'CLU', 'SOD3']",0.8469976306984066,0,0,10
186,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3386909324522853,1.0858856237454506,1.175652846744923,"['PLOD3', 'HSPB1', 'NRARP', 'PBXIP1', 'PLA2G5', 'ETS1', 'NDRG1', 'APOLD1', 'ICAM1', 'TUBA1C', 'STIP1', 'GJA1', 'CSRP1', 'ADAMTS1', 'DNAJB4', 'CCL2', 'FLNB', 'MYH11', 'TMSB10', 'ADAMTS9', 'HSP90AA1', 'SDF2L1', 'EGR3', 'GAB1', 'NFATC2', 'RHOC', 'SOD2', 'VEGFA', 'DNAJA1', 'RCN1', 'TXNIP', 'FAS', 'MYH9', 'ACKR3', 'RPL26', 'DSC1', 'ENG', 'ARF6', 'HSPA1A', 'EPHA2']",0.8469976306984066,0,0,40
187,Cancer immunotherapy by PD-1 blockade WP4585,0.3426336603968126,1.794147768836869,1.9216999200769735,"['NFATC2', 'PDCD1LG2']",0.8469976306984066,0,0,2
188,Computational Model of Aerobic Glycolysis WP4629,0.3426336603968126,1.794147768836869,1.9216999200769735,"['PGAM2', 'SLC2A1']",0.8469976306984066,0,0,2
189,FOXA2 pathway WP5066,0.3426336603968126,1.794147768836869,1.9216999200769735,"['IRS1', 'IRS2']",0.8469976306984066,0,0,2
190,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3426336603968126,1.794147768836869,1.9216999200769735,"['CCL2', 'NFKB2']",0.8469976306984066,0,0,2
191,Overview of nanoparticle effects WP3287,0.3426336603968126,1.794147768836869,1.9216999200769735,"['PIK3CD', 'HMOX1']",0.8469976306984066,0,0,2
192,Benzo(a)pyrene metabolism WP696,0.34495706733936066,2.989766081871345,3.182113616120603,['EPHX1'],0.8469976306984066,0,0,1
193,Cells and molecules involved in local acute inflammatory response  WP4493,0.34495706733936066,2.989766081871345,3.182113616120603,['ICAM1'],0.8469976306984066,0,0,1
194,Composition of Lipid Particles WP3601,0.34495706733936066,2.989766081871345,3.182113616120603,['APOE'],0.8469976306984066,0,0,1
195,FTO Obesity Variant Mechanism WP3407,0.34495706733936066,2.989766081871345,3.182113616120603,['ARID5B'],0.8469976306984066,0,0,1
196,GABA metabolism (aka GHB) WP4157,0.34495706733936066,2.989766081871345,3.182113616120603,['ADHFE1'],0.8469976306984066,0,0,1
197,Irinotecan pathway WP229,0.34495706733936066,2.989766081871345,3.182113616120603,['CYP3A5'],0.8469976306984066,0,0,1
198,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.34495706733936066,2.989766081871345,3.182113616120603,['CDKN1A'],0.8469976306984066,0,0,1
199,Small Ligand GPCRs WP247,0.34495706733936066,2.989766081871345,3.182113616120603,['S1PR3'],0.8469976306984066,0,0,1
200,Somatic sex determination WP4814,0.34495706733936066,2.989766081871345,3.182113616120603,['SOX9'],0.8469976306984066,0,0,1
201,Tamoxifen metabolism WP691,0.34495706733936066,2.989766081871345,3.182113616120603,['CYP3A5'],0.8469976306984066,0,0,1
202,The alternative pathway of fetal androgen synthesis WP4524,0.34495706733936066,2.989766081871345,3.182113616120603,['HSD17B6'],0.8469976306984066,0,0,1
203,Cardiac Hypertrophic Response WP2795,0.349944257729051,1.2819410963211404,1.3460143080759974,"['EGF', 'NFATC2', 'NRG1', 'FGF2', 'MAP3K14', 'TNFRSF1A']",0.8469976306984066,0,0,6
204,RANKL/RANK signaling pathway WP2018,0.349944257729051,1.2819410963211404,1.3460143080759974,"['SPI1', 'TNFRSF11B', 'TAB2', 'FOS', 'ICAM1', 'NFKB2']",0.8469976306984066,0,0,6
205,Senescence and Autophagy in Cancer WP615,0.3523719398185831,1.2055970149253732,1.2575196840797693,"['CDKN1A', 'CEBPB', 'IGFBP5', 'IFI16', 'IRF7', 'COL10A1', 'SLC39A1', 'CD44', 'IGF1R']",0.8469976306984066,0,0,9
206,Glycogen Synthesis and Degradation WP500,0.3531557724764083,1.3195402794548905,1.373438271300685,"['HKDC1', 'PYGM', 'PYGL', 'GYG2', 'HK2']",0.8469976306984066,0,0,5
207,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3531557724764083,1.3195402794548905,1.373438271300685,"['AHSA1', 'NFATC2', 'PRKCQ', 'FOS', 'MAP3K14']",0.8469976306984066,0,0,5
208,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.35369898200744293,1.4952415812591509,1.554018123635766,"['CDKN1A', 'SOX9', 'FGFR3']",0.8469976306984066,0,0,3
209,Bladder cancer WP2828,0.35502894699933213,1.3803324880247958,1.4294115236962142,"['CDKN1A', 'EGF', 'FGFR3', 'VEGFA']",0.8469976306984066,0,0,4
210,Neural Crest Cell Migration during Development WP4564,0.35502894699933213,1.3803324880247958,1.4294115236962142,"['BDNF', 'PIK3CD', 'FOS', 'EPHB1']",0.8469976306984066,0,0,4
211,Small cell lung cancer WP4658,0.36706930436368024,1.1877703287197232,1.1903888973152805,"['LAMA5', 'CDKN1A', 'CCNE2', 'LAMA2', 'GADD45B', 'LAMB2', 'GADD45A', 'PIK3CD', 'LAMB1']",0.8715721397450418,0,0,9
212,Oxidative Damage WP3941,0.37874647386777205,1.3291005291005291,1.290408063010787,"['C1QB', 'CDKN1A', 'C1R', 'GADD45A']",0.886441003170239,0,0,4
213,Toll-like Receptor Signaling Pathway WP75,0.38006166810015724,1.2078815090929629,1.1685308493035726,"['IFNAR2', 'TICAM2', 'IRF7', 'PIK3CD', 'TAB2', 'FOS', 'MYD88']",0.886441003170239,0,0,7
214,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3804126975660244,1.630910420961628,1.5762725886086406,"['RYR2', 'CD38']",0.886441003170239,0,0,2
215,TP53 network WP1742,0.3804126975660244,1.630910420961628,1.5762725886086406,"['CDKN1A', 'GADD45A']",0.886441003170239,0,0,2
216,Heart Development WP1591,0.38217815705543234,1.4164290668105108,1.3624183593149075,"['SMAD1', 'NFATC2', 'VEGFA']",0.886441003170239,0,0,3
217,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.40010669665190923,1.121683861459101,1.027489366463916,"['FZD1', 'NOTCH3', 'CLDN4', 'CLDN20', 'FZD5', 'MMP15', 'FZD7', 'ID2', 'WNT7B', 'FZD9', 'PIK3CD', 'WNT7A']",0.893310718650293,0,0,12
218,Corticotropin-releasing hormone signaling pathway WP2355,0.4049846223868868,1.1576876585053684,1.0464410313614771,"['GJA1', 'HSP90AA1', 'IL18', 'PLCG2', 'PRKCQ', 'FOS', 'JUNB', 'FOSL2']",0.893310718650293,0,0,8
219,Glioblastoma signaling pathways WP2261,0.4049846223868868,1.1576876585053684,1.0464410313614771,"['CDKN1A', 'IRS1', 'GAB1', 'PLCG2', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'IGF1R']",0.893310718650293,0,0,8
220,Cell migration and invasion through p75NTR WP4561,0.4103633400805924,1.345497803806735,1.1984514655458671,"['EFNA1', 'EFNB1', 'BDNF']",0.893310718650293,0,0,3
221,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.4107110177046063,2.2421418128654973,1.9952044923072083,['GSTP1'],0.893310718650293,0,0,1
222,Bile acids synthesis and enterohepatic circulation  WP4389,0.4107110177046063,2.2421418128654973,1.9952044923072083,['SLC10A1'],0.893310718650293,0,0,1
223,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.4107110177046063,2.2421418128654973,1.9952044923072083,['HSD11B1'],0.893310718650293,0,0,1
224,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.4107110177046063,2.2421418128654973,1.9952044923072083,['STRADB'],0.893310718650293,0,0,1
225,NAD Biosynthesis II (from tryptophan) WP2485,0.4107110177046063,2.2421418128654973,1.9952044923072083,['HAAO'],0.893310718650293,0,0,1
226,Osteoblast Signaling WP322,0.4107110177046063,2.2421418128654973,1.9952044923072083,['TNFRSF11B'],0.893310718650293,0,0,1
227,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.4107110177046063,2.2421418128654973,1.9952044923072083,['VEGFA'],0.893310718650293,0,0,1
228,SARS-CoV-2 and COVID-19 Pathway WP4846,0.4107110177046063,2.2421418128654973,1.9952044923072083,['NRP1'],0.893310718650293,0,0,1
229,Serotonin Transporter Activity WP1455,0.4107110177046063,2.2421418128654973,1.9952044923072083,['IL1R1'],0.893310718650293,0,0,1
230,T-cell receptor (TCR) signaling pathway WP69,0.41411696801393366,1.1629548050252896,1.0252688800501941,"['WAS', 'NFATC2', 'FAS', 'PRKCQ', 'FOS', 'VIM', 'MAP3K14']",0.893310718650293,0,0,7
231,Metapathway biotransformation Phase I and II WP702,0.4168346058916383,1.121504782928624,0.9813904401724052,"['CYP39A1', 'HS3ST3B1', 'CHST6', 'HS3ST3A1', 'GPX3', 'GSTP1', 'CYP4F3', 'EPHX1', 'CYP3A5', 'CYP3A7']",0.893310718650293,0,0,10
232,Cysteine and methionine catabolism WP4504,0.4172349464354662,1.4948792977322605,1.3066826571775567,"['BHMT', 'SQOR']",0.893310718650293,0,0,2
233,Imatinib and Chronic Myeloid Leukemia WP3640,0.4172349464354662,1.4948792977322605,1.3066826571775567,"['GADD45A', 'PIM1']",0.893310718650293,0,0,2
234,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4172349464354662,1.4948792977322605,1.3066826571775567,"['TNC', 'VIM']",0.893310718650293,0,0,2
235,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.4242372543031333,1.170085170180867,1.0033040595360532,"['RYR2', 'GJA1', 'LAMA2', 'ACTN1', 'CACNA2D3', 'DSC2']",0.9039790826034035,0,0,6
236,Neural Crest Cell Migration in Cancer WP4565,0.42582647404072504,1.2372363268914992,1.0562575462266348,"['BDNF', 'PIK3CD', 'FOS', 'EPHB1']",0.9039790826034035,0,0,4
237,Head and Neck Squamous Cell Carcinoma WP4674,0.4311055940510348,1.1417167267387531,0.9606429897304223,"['CDKN1A', 'SESN1', 'GAB1', 'FGFR3', 'IGF1R', 'NFKB2', 'VEGFA']",0.9113244836268711,0,0,7
238,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.43813658412790835,1.281321899184271,1.0573783277750293,"['HSPB8', 'HSPB1', 'NDRG1']",0.9146101193670086,0,0,3
239,MTHFR deficiency WP4288,0.43813658412790835,1.281321899184271,1.0573783277750293,"['BHMT', 'CHDH', 'GRIN2D']",0.9146101193670086,0,0,3
240,Tryptophan metabolism WP465,0.43813658412790835,1.281321899184271,1.0573783277750293,"['MAOB', 'AADAT', 'HAAO']",0.9146101193670086,0,0,3
241,Constitutive Androstane Receptor Pathway WP2875,0.45291198117577863,1.3797760396151033,1.09286192520058,"['HSP90AA1', 'CYP3A5']",0.930451728264843,0,0,2
242,ERK Pathway in Huntington's Disease WP3853,0.45291198117577863,1.3797760396151033,1.09286192520058,"['EGF', 'BDNF']",0.930451728264843,0,0,2
243,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.45291198117577863,1.3797760396151033,1.09286192520058,"['ACTN1', 'PRKCQ']",0.930451728264843,0,0,2
244,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.46103532957474685,1.1211482024944974,0.8680833052711792,"['FZD1', 'CDKN1A', 'DAAM1', 'FZD5', 'FZD7', 'FZD9']",0.930451728264843,0,0,6
245,Resistin as a regulator of inflammation WP4481,0.46539551527650735,1.222980167709304,0.9354179845295091,"['PLCG2', 'PIK3CD', 'PLCE1']",0.930451728264843,0,0,3
246,Aspirin and miRNAs WP4707,0.4698688368283539,1.7935672514619883,1.3546843829796258,['VEGFA'],0.930451728264843,0,0,1
247,EDA signaling in hair follicle development WP3930,0.4698688368283539,1.7935672514619883,1.3546843829796258,['BMP1'],0.930451728264843,0,0,1
248,Genes targeted by miRNAs in adipocytes WP1992,0.4698688368283539,1.7935672514619883,1.3546843829796258,['GJA1'],0.930451728264843,0,0,1
249,HIF1A and PPARG regulation of glycolysis WP2456,0.4698688368283539,1.7935672514619883,1.3546843829796258,['SLC2A1'],0.930451728264843,0,0,1
250,LDLRAD4 and what we know about it WP4904,0.4698688368283539,1.7935672514619883,1.3546843829796258,['NEDD4'],0.930451728264843,0,0,1
251,"Phase I biotransformations, non P450 WP136",0.4698688368283539,1.7935672514619883,1.3546843829796258,['PON1'],0.930451728264843,0,0,1
252,PTF1A related regulatory pathway WP4147,0.4698688368283539,1.7935672514619883,1.3546843829796258,['HES1'],0.930451728264843,0,0,1
253,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.4698688368283539,1.7935672514619883,1.3546843829796258,['IGF1R'],0.930451728264843,0,0,1
254,Nephrotic syndrome WP4758,0.4719438666303672,1.157225570128796,0.8689551572872014,"['CD151', 'LAMB2', 'PLCE1', 'MYH9']",0.9308814062276141,0,0,4
255,Calcium Regulation in the Cardiac Cell WP536,0.48855520120766827,1.0448519363816529,0.7484303806081526,"['RYR2', 'RGS17', 'GJA1', 'PLN', 'GRK5', 'RGS16', 'CHRM5', 'ATP1A4', 'CACNA1A', 'GJA9', 'PRKCQ', 'ADCY2']",0.95180812542851,0,0,12
256,Focal Adhesion WP306,0.49106448840767636,1.0347971821383934,0.7359268725495933,"['LAMA5', 'LAMA2', 'EGF', 'LAMB2', 'ACTN1', 'HGF', 'TNC', 'PIK3CD', 'LAMB1', 'VEGFA', 'IGF1R', 'THBS3', 'COL6A2', 'FLNA', 'FLNB']",0.95180812542851,0,0,15
257,Oxysterols derived from cholesterol WP4545,0.49205250396404016,1.169711630275638,0.829524224672069,"['CYP39A1', 'HSD3B7', 'ACOT6']",0.95180812542851,0,0,3
258,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.49205250396404016,1.169711630275638,0.829524224672069,"['ANGPT2', 'SLC2A1', 'VEGFA']",0.95180812542851,0,0,3
259,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.49205250396404016,1.169711630275638,0.829524224672069,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.95180812542851,0,0,3
260,IL-6 signaling pathway WP364,0.4944830685143718,1.120970695970696,0.7894350575151108,"['SOCS3', 'GAB1', 'TIMP1', 'JUNB']",0.9528308358680779,0,0,4
261,Retinoblastoma gene in cancer WP2446,0.49812010583997146,1.0639637621643148,0.7414912994909717,"['CCNA2', 'BARD1', 'CDKN1A', 'CCNE2', 'RPA3', 'RBP1', 'CDC7']",0.9551729701877197,0,0,7
262,DNA damage response (only ATM dependent) WP710,0.499511613152061,1.04816653934301,0.7275580033542131,"['CDKN1A', 'BCL6', 'IRS1', 'WNT7B', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'SOD2', 'NFKB2']",0.9551729701877197,0,0,9
263,Myometrial relaxation and contraction pathways WP289,0.5134233258080716,1.0247815559532583,0.6831753153079414,"['ACTA2', 'RYR2', 'RGS17', 'GJA1', 'IGFBP5', 'GRK5', 'RGS16', 'PLCG2', 'ACKR3', 'PRKCQ', 'ADCY2', 'FOS']",0.9564561410295792,0,0,12
264,TNF-alpha signaling pathway WP231,0.5141517930231085,1.039644762482829,0.691609892509445,"['HSP90AA1', 'OTUD7B', 'CCL2', 'TAB2', 'PYGL', 'MAP3K14', 'TNFRSF1A', 'NFKB2']",0.9564561410295792,0,0,8
265,Statin inhibition of cholesterol production WP430,0.5203060862758994,1.1956108266276517,0.7811380019410812,"['APOC1', 'APOE']",0.9564561410295792,0,0,2
266,Urea cycle and metabolism of amino groups WP497,0.5203060862758994,1.1956108266276517,0.7811380019410812,"['ARG2', 'PYCR1']",0.9564561410295792,0,0,2
267,Caloric restriction and aging WP4191,0.5230917817207679,1.4945175438596492,0.968444886703002,['NAMPT'],0.9564561410295792,0,0,1
268,"Cerebral organic acidurias, including diseases WP4519",0.5230917817207679,1.4945175438596492,0.968444886703002,['ADHFE1'],0.9564561410295792,0,0,1
269,Dual hijack model of Vif in HIV infection WP3300,0.5230917817207679,1.4945175438596492,0.968444886703002,['RUNX1'],0.9564561410295792,0,0,1
270,Estrogen metabolism WP697,0.5230917817207679,1.4945175438596492,0.968444886703002,['NQO1'],0.9564561410295792,0,0,1
271,Ketogenesis and Ketolysis WP4742,0.5230917817207679,1.4945175438596492,0.968444886703002,['SLC2A1'],0.9564561410295792,0,0,1
272,Methylation Pathways WP704,0.5230917817207679,1.4945175438596492,0.968444886703002,['PNMT'],0.9564561410295792,0,0,1
273,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5230917817207679,1.4945175438596492,0.968444886703002,['MUC1'],0.9564561410295792,0,0,1
274,Role of Osx and miRNAs in tooth development WP3971,0.5230917817207679,1.4945175438596492,0.968444886703002,['NOTCH3'],0.9564561410295792,0,0,1
275,Integrated breast cancer pathway WP1984,0.525165042788884,1.013556496088239,0.6527736609005242,"['BARD1', 'SMAD1', 'PLK3', 'IRS1', 'GADD45A', 'XRCC3', 'PML', 'FOSL2', 'VEGFA', 'ITPKC', 'RASGEF1A', 'CHEK2', 'FILIP1']",0.9567552234081123,0,0,13
276,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5432782164725111,1.0759590043923866,0.656478871068879,"['IFNAR2', 'FOS', 'MYD88']",0.9842509969429355,0,0,3
277,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5518539214932715,1.1207937088514996,0.666280368638518,"['UGCG', 'ST6GALNAC3']",0.9842509969429355,0,0,2
278,NAD+ biosynthetic pathways WP3645,0.5518539214932715,1.1207937088514996,0.666280368638518,"['NAMPT', 'CD38']",0.9842509969429355,0,0,2
279,Urea cycle and associated pathways WP4595,0.5518539214932715,1.1207937088514996,0.666280368638518,"['PYCR1', 'GPT']",0.9842509969429355,0,0,2
280,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.5624218598192304,0.996084189916789,0.5732495097040803,"['FZD1', 'EGF', 'PIK3CD', 'NRG1', 'FGF2', 'MAP3K14', 'IGF1R']",0.9842509969429355,0,0,7
281,Melanoma WP4685,0.5667425179186377,0.9960870628515529,0.56562822930447,"['CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'FOS', 'ETS1']",0.9842509969429355,0,0,6
282,Prion disease pathway WP3995,0.5677367575228693,1.034491496790179,0.5856229701947263,"['SPI1', 'HSPA5', 'EBF1']",0.9842509969429355,0,0,3
283,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.5709748628156468,1.2809106098579783,0.7178352344884841,['HMOX1'],0.9842509969429355,0,0,1
284,LTF danger signal response pathway WP4478,0.5709748628156468,1.2809106098579783,0.7178352344884841,['MYD88'],0.9842509969429355,0,0,1
285,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5709748628156468,1.2809106098579783,0.7178352344884841,['CLDN4'],0.9842509969429355,0,0,1
286,Nanoparticle triggered regulated necrosis WP2513,0.5709748628156468,1.2809106098579783,0.7178352344884841,['TNFRSF1A'],0.9842509969429355,0,0,1
287,Osteoclast Signaling WP12,0.5709748628156468,1.2809106098579783,0.7178352344884841,['TNFRSF11B'],0.9842509969429355,0,0,1
288,RAS and bradykinin pathways in COVID-19 WP4969,0.5709748628156468,1.2809106098579783,0.7178352344884841,['SERPING1'],0.9842509969429355,0,0,1
289,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5709748628156468,1.2809106098579783,0.7178352344884841,['MYD88'],0.9842509969429355,0,0,1
290,B Cell Receptor Signaling Pathway WP23,0.5779134897811392,0.9804400697503671,0.5376057752344867,"['BCL6', 'CD81', 'INPP5D', 'PLCG2', 'GAB1', 'NFATC2', 'ETS1']",0.9842509969429355,0,0,7
291,Insulin Signaling WP481,0.580314704983457,0.9726594010126148,0.5293063913762661,"['IRS1', 'SLC2A1', 'GAB1', 'PIK3CD', 'IRS2', 'SLC2A4', 'FOS', 'PIK3C2A', 'IGF1R', 'SOCS3', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'ARF6']",0.9842509969429355,0,0,14
292,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5819058724433045,1.0547786049313654,0.571106263579942,"['H2AFY2', 'BCL6']",0.9842509969429355,0,0,2
293,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5819058724433045,1.0547786049313654,0.571106263579942,"['SLC2A1', 'VEGFA']",0.9842509969429355,0,0,2
294,Hippo-Yap signaling pathway WP4537,0.5819058724433045,1.0547786049313654,0.571106263579942,"['NDRG1', 'TEAD3']",0.9842509969429355,0,0,2
295,Methionine De Novo and Salvage Pathway WP3580,0.5819058724433045,1.0547786049313654,0.571106263579942,"['BHMT', 'CHDH']",0.9842509969429355,0,0,2
296,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.5819058724433045,1.0547786049313654,0.571106263579942,"['WIF1', 'PML']",0.9842509969429355,0,0,2
297,Cell cycle WP179,0.5834781359122791,0.9719170800850461,0.5236186732225653,"['CCNB3', 'CCNA2', 'CDKN1A', 'CCNE2', 'GADD45B', 'GADD45A', 'CHEK2', 'CDC7', 'SMC1B']",0.9842509969429355,0,0,9
298,ATM Signaling Pathway WP2516,0.5913709426141683,0.9960956564177648,0.5232608082116413,"['CDKN1A', 'GADD45A', 'CHEK2']",0.9925490696285737,0,0,3
299,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6009047536118426,0.9570756538027082,0.487456658775475,"['SLCO1C1', 'IRS1', 'DIO2', 'SLC2A1', 'TRIP10', 'PIK3CD', 'IRS2', 'SLC2A4', 'MAP3K6', 'PIK3C2A', 'MAP3K14']",0.9925490696285737,0,0,11
300,7-oxo-C and 7beta-HC pathways WP5064,0.6104442797712972,0.9960985125579127,0.4916426090566565,"['HSD11B1', 'ACOT6']",0.9925490696285737,0,0,2
301,Canonical and non-canonical Notch signaling WP3845,0.6104442797712972,0.9960985125579127,0.4916426090566565,"['NOTCH3', 'HES1']",0.9925490696285737,0,0,2
302,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6104442797712972,0.9960985125579127,0.4916426090566565,"['CEBPB', 'ATP2C2']",0.9925490696285737,0,0,2
303,Cancer immunotherapy by CTLA4 blockade WP4582,0.6140534761467455,1.1207054093567252,0.5465380603976717,['PIK3CD'],0.9925490696285737,0,0,1
304,"Degradation pathway of sphingolipids, including diseases WP4153",0.6140534761467455,1.1207054093567252,0.5465380603976717,['NEU4'],0.9925490696285737,0,0,1
305,Estrogen Receptor Pathway WP2881,0.6140534761467455,1.1207054093567252,0.5465380603976717,['PDK4'],0.9925490696285737,0,0,1
306,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.6140534761467455,1.1207054093567252,0.5465380603976717,['CEBPB'],0.9925490696285737,0,0,1
307,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6140534761467455,1.1207054093567252,0.5465380603976717,['BHMT'],0.9925490696285737,0,0,1
308,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6140534761467455,1.1207054093567252,0.5465380603976717,['PRKCQ'],0.9925490696285737,0,0,1
309,NLR Proteins WP288,0.6140534761467455,1.1207054093567252,0.5465380603976717,['ERBIN'],0.9925490696285737,0,0,1
310,Vitamin D-sensitive calcium signaling in depression WP4698,0.614152118931852,0.9604423760719515,0.46822778950676597,"['ATP2B4', 'PVALB', 'GRIN2D']",0.9925490696285737,0,0,3
311,Pathogenic Escherichia coli infection WP2272,0.6195538486338734,0.943512627723154,0.45171200981913495,"['TUBA1C', 'TUBB2B', 'TUBA1A', 'WAS']",0.998059415323378,0,0,4
312,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6360604132747906,0.9272479426465391,0.4195442089433235,"['HGF', 'GAB1', 'FOS']",0.9997914403277198,0,0,3
313,EPO Receptor Signaling WP581,0.637470078127989,0.9435952720132446,0.42485182677692473,"['IRS1', 'IRS2']",0.9997914403277198,0,0,2
314,SARS-CoV-2 mitochondrial interactions WP5038,0.637470078127989,0.9435952720132446,0.42485182677692473,"['IRF7', 'NFKB2']",0.9997914403277198,0,0,2
315,Unfolded protein response WP4925,0.637470078127989,0.9435952720132446,0.42485182677692473,"['HSPA5', 'TXNIP']",0.9997914403277198,0,0,2
316,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6421655393038428,0.9144772278412832,0.4050303400419714,"['IFNAR2', 'SOCS3', 'IL3RA', 'OSMR', 'IL12RB2']",0.9997914403277198,0,0,5
317,Non-small cell lung cancer WP4255,0.6465027900721796,0.9112998495343024,0.39748873172647653,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PLCG2', 'PIK3CD']",0.9997914403277198,0,0,6
318,15q13.3 copy number variation syndrome WP4942,0.6528093721815481,0.9961013645224172,0.42480746700527794,['CHRNA7'],0.9997914403277198,0,0,1
319,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.6528093721815481,0.9961013645224172,0.42480746700527794,['SMAD1'],0.9997914403277198,0,0,1
320,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.6528093721815481,0.9961013645224172,0.42480746700527794,['PRKCQ'],0.9997914403277198,0,0,1
321,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6528093721815481,0.9961013645224172,0.42480746700527794,['ADCY2'],0.9997914403277198,0,0,1
322,miRNAs involved in DNA damage response WP1545,0.6528093721815481,0.9961013645224172,0.42480746700527794,['CDKN1A'],0.9997914403277198,0,0,1
323,Neuroinflammation WP4919,0.6528093721815481,0.9961013645224172,0.42480746700527794,['FOS'],0.9997914403277198,0,0,1
324,Osteopontin Signaling WP1434,0.6528093721815481,0.9961013645224172,0.42480746700527794,['MAP3K14'],0.9997914403277198,0,0,1
325,Trans-sulfuration pathway WP2333,0.6528093721815481,0.9961013645224172,0.42480746700527794,['GCLM'],0.9997914403277198,0,0,1
326,Synaptic Vesicle Pathway WP2267,0.6566498089056201,0.8961904761904762,0.37694167362393105,"['SLC22A3', 'SLC38A1', 'CACNA1A', 'SYN3']",0.9997914403277198,0,0,4
327,Hepatitis C and Hepatocellular Carcinoma WP3646,0.657083789129332,0.8962664714494876,0.3763814902101466,"['CDKN1A', 'CD44', 'VEGFA']",0.9997914403277198,0,0,3
328,MET in type 1 papillary renal cell carcinoma WP4205,0.658460314381684,0.8961143695014663,0.37444230898678227,"['CDKN1A', 'HGF', 'GAB1', 'PIK3CD', 'ETS1']",0.9997914403277198,0,0,5
329,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6629992468916398,0.8963423555230432,0.3683800582980575,"['TGFBR3', 'HGF']",0.9997914403277198,0,0,2
330,DNA Replication WP466,0.6772171510437232,0.8672838048457941,0.33803540009900673,"['RPA3', 'UBC', 'CDC7']",0.9997914403277198,0,0,3
331,IL-2 signaling pathway WP49,0.6772171510437232,0.8672838048457941,0.33803540009900673,"['SOCS3', 'FOS', 'NMI']",0.9997914403277198,0,0,3
332,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6772171510437232,0.8672838048457941,0.33803540009900673,"['CCL2', 'MAP3K14', 'NFKB2']",0.9997914403277198,0,0,3
333,Hepatitis B infection WP4666,0.6801900100619422,0.8956553755522828,0.34517043914555945,"['CDKN1A', 'TICAM2', 'EGR3', 'SLC10A1', 'IRF7', 'NFATC2', 'PIK3CD', 'FAS', 'TAB2', 'FOS', 'MYD88']",0.9997914403277198,0,0,11
334,Endothelin Pathways WP2197,0.6870597854120161,0.8535897167938133,0.32038121430163313,"['EDNRA', 'CALCRL']",0.9997914403277198,0,0,2
335,Pre-implantation embryo WP3527,0.6870597854120161,0.8535897167938133,0.32038121430163313,"['ZFP36', 'H2AFY2']",0.9997914403277198,0,0,2
336,Alanine and aspartate metabolism WP106,0.6876760275554307,0.8964181286549707,0.3356525111756227,['GPT'],0.9997914403277198,0,0,1
337,Biomarkers for pyrimidine metabolism disorders WP4584,0.6876760275554307,0.8964181286549707,0.3356525111756227,['DHODH'],0.9997914403277198,0,0,1
338,Dopaminergic Neurogenesis WP2855,0.6876760275554307,0.8964181286549707,0.3356525111756227,['GLI2'],0.9997914403277198,0,0,1
339,Ganglio Sphingolipid Metabolism WP1423,0.6876760275554307,0.8964181286549707,0.3356525111756227,['ST8SIA1'],0.9997914403277198,0,0,1
340,GDNF/RET signaling axis WP4830,0.6876760275554307,0.8964181286549707,0.3356525111756227,['IFT27'],0.9997914403277198,0,0,1
341,Mammalian disorder of sexual development WP4842,0.6876760275554307,0.8964181286549707,0.3356525111756227,['SOX9'],0.9997914403277198,0,0,1
342,"NAD metabolism, sirtuins and aging WP3630",0.6876760275554307,0.8964181286549707,0.3356525111756227,['NAMPT'],0.9997914403277198,0,0,1
343,RalA downstream regulated genes WP2290,0.6876760275554307,0.8964181286549707,0.3356525111756227,['YBX3'],0.9997914403277198,0,0,1
344,AMP-activated protein kinase (AMPK) signaling WP1403,0.6895844485539562,0.8615074441687345,0.3201931216196988,"['CCNA2', 'CDKN1A', 'STRADB', 'PIK3CD', 'SLC2A4']",0.9997914403277198,0,0,5
345,Alzheimer's disease WP2059,0.6898240536921664,0.8669916928975457,0.32193023573595597,"['PSENEN', 'FAS', 'ATP2A1', 'APOE', 'TNFRSF1A', 'GRIN2D']",0.9997914403277198,0,0,6
346,G1 to S cell cycle control WP45,0.6912286036429955,0.853375196232339,0.3151383860584954,"['CDKN1A', 'CCNE2', 'GADD45A', 'RPA3']",0.9997914403277198,0,0,4
347,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6964615023440603,0.8401125549048316,0.3039046345792607,"['HSPB1', 'FAS', 'LMNB1']",0.9997914403277198,0,0,3
348,G13 Signaling Pathway WP524,0.6964615023440603,0.8401125549048316,0.3039046345792607,"['WAS', 'PIK3CD', 'PIP4K2A']",0.9997914403277198,0,0,3
349,Integrated Cancer Pathway WP1971,0.6964615023440603,0.8401125549048316,0.3039046345792607,"['BARD1', 'CDKN1A', 'CHEK2']",0.9997914403277198,0,0,3
350,Gastric Cancer Network 2 WP2363,0.7096891426272423,0.8147236815854226,0.27939175178155223,"['DSCC1', 'S100A6']",0.9999339763753385,0,0,2
351,Hedgehog Signaling Pathway WP4249,0.7148231585609286,0.8145880473845335,0.27347357874193395,"['HHIP', 'BOC', 'GLI2']",0.9999339763753385,0,0,3
352,22q11.2 copy number variation syndrome WP4657,0.7161472301755288,0.8472536413065047,0.2828721533439325,"['ACTA2', 'AIFM3', 'SERPIND1', 'HIST1H4H', 'HES1', 'SLC2A4', 'PRODH']",0.9999339763753385,0,0,7
353,Amino Acid metabolism WP3925,0.7166790154027736,0.8397606382978723,0.27974712344381325,"['PNMT', 'ARG2', 'BHMT', 'PDK4', 'PYCR1', 'GCLM']",0.9999339763753385,0,0,6
354,BMP Signaling Pathway in Eyelid Development WP3927,0.7190434789273833,0.8148591174906964,0.26876779537298917,['SMAD1'],0.9999339763753385,0,0,1
355,Cell Differentiation - Index expanded WP2023,0.7190434789273833,0.8148591174906964,0.26876779537298917,['ID2'],0.9999339763753385,0,0,1
356,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7190434789273833,0.8148591174906964,0.26876779537298917,['MAP3K14'],0.9999339763753385,0,0,1
357,Pyrimidine metabolism and related diseases WP4225,0.7190434789273833,0.8148591174906964,0.26876779537298917,['DHODH'],0.9999339763753385,0,0,1
358,Serotonin and anxiety WP3947,0.7190434789273833,0.8148591174906964,0.26876779537298917,['FOS'],0.9999339763753385,0,0,1
359,ErbB signaling pathway WP673,0.739744239358216,0.824822242831749,0.24864330435044696,"['CDKN1A', 'NRG4', 'EGF', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1']",0.9999339763753385,0,0,7
360,Canonical and non-canonical TGF-B signaling WP3874,0.7472626735790007,0.7468932748538012,0.21759877955273077,['BMP1'],0.9999339763753385,0,0,1
361,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.7472626735790007,0.7468932748538012,0.21759877955273077,['SYTL4'],0.9999339763753385,0,0,1
362,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.7472626735790007,0.7468932748538012,0.21759877955273077,['ALOX12'],0.9999339763753385,0,0,1
363,Hedgehog Signaling Pathway Netpath WP47,0.7472626735790007,0.7468932748538012,0.21759877955273077,['GLI2'],0.9999339763753385,0,0,1
364,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7472626735790007,0.7468932748538012,0.21759877955273077,['SOX9'],0.9999339763753385,0,0,1
365,Omega-3/Omega-6 FA synthesis WP4723,0.7472626735790007,0.7468932748538012,0.21759877955273077,['PLA2G5'],0.9999339763753385,0,0,1
366,PPAR-alpha pathway WP2878,0.7472626735790007,0.7468932748538012,0.21759877955273077,['DBI'],0.9999339763753385,0,0,1
367,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7508386438890043,0.7467081199707388,0.2139800430108451,"['PIK3CD', 'PRKCQ']",0.9999339763753385,0,0,2
368,One-carbon metabolism WP241,0.7508386438890043,0.7467081199707388,0.2139800430108451,"['BHMT', 'CHDH']",0.9999339763753385,0,0,2
369,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7508386438890043,0.7467081199707388,0.2139800430108451,"['NDRG1', 'TEAD3']",0.9999339763753385,0,0,2
370,Kit receptor signaling pathway WP304,0.7527465999458737,0.778913839783405,0.22123227178560192,"['KITLG', 'INPP5D', 'FOS', 'JUNB']",0.9999339763753385,0,0,4
371,Regulation of Actin Cytoskeleton WP51,0.7582601552283418,0.8288365628321478,0.22936289730185144,"['MRAS', 'EGF', 'ACTN1', 'CHRM5', 'WAS', 'PIP4K2A', 'PIK3CD', 'PIK3C2A', 'FGF2', 'FGFR3']",0.9999339763753385,0,0,10
372,Netrin-UNC5B signaling pathway WP4747,0.7647398988916794,0.7465226939970717,0.2002319470206727,"['INPP5D', 'CCL2', 'ICAM1']",0.9999339763753385,0,0,3
373,Prolactin Signaling Pathway WP2037,0.7709980622292244,0.772006775204773,0.2007753532934219,"['SOCS3', 'IRS1', 'FLNA', 'IRS2', 'FOS']",0.9999339763753385,0,0,5
374,Airway smooth muscle cell contraction WP4962,0.7726493842112455,0.6893837156995052,0.1778126806320714,['CD38'],0.9999339763753385,0,0,1
375,SARS coronavirus and innate immunity WP4912,0.7726493842112455,0.6893837156995052,0.1778126806320714,['IFNAR2'],0.9999339763753385,0,0,1
376,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7726493842112455,0.6893837156995052,0.1778126806320714,['NQO1'],0.9999339763753385,0,0,1
377,TGF-beta Signaling Pathway WP366,0.7775492712683311,0.8055661764705883,0.20268710843173451,"['TGFBR3', 'CDKN1A', 'KLF6', 'LIMK2', 'TNC', 'FOS', 'ETS1', 'JUNB', 'PML']",0.9999339763753385,0,0,9
378,Circadian rhythm related genes WP3594,0.7835664001282787,0.8196346903531027,0.1999084687733234,"['CST3', 'CLDN4', 'EGR3', 'NFIL3', 'ID2', 'NAMPT', 'UBC', 'ID3', 'FAS', 'GHRL', 'CARTPT', 'PML']",0.9999339763753385,0,0,12
379,BDNF-TrkB Signaling WP3676,0.7868618142565665,0.6891564909121602,0.1651926243348495,"['BDNF', 'GAB1']",0.9999339763753385,0,0,2
380,Trans-sulfuration and one-carbon metabolism WP2525,0.7868618142565665,0.6891564909121602,0.1651926243348495,"['BHMT', 'GCLM']",0.9999339763753385,0,0,2
381,Modulators of TCR signaling and T cell activation WP5072,0.793896930106773,0.7071164367727518,0.16320363123441392,"['PRKCQ', 'MAP3K14', 'ZFP36L1']",0.9999339763753385,0,0,3
382,Cholesterol Biosynthesis Pathway WP197,0.795487732214595,0.6400898078529658,0.14645245381603508,['MSMO1'],0.9999339763753385,0,0,1
383,MAPK pathway in congenital thyroid cancer WP4928,0.795487732214595,0.6400898078529658,0.14645245381603508,['FOS'],0.9999339763753385,0,0,1
384,Overview of interferons-mediated signaling pathway WP4558,0.795487732214595,0.6400898078529658,0.14645245381603508,['IFNAR2'],0.9999339763753385,0,0,1
385,7q11.23 copy number variation syndrome WP4932,0.8021158897775645,0.7640933347659468,0.16848424648662322,"['CLIP2', 'CLDN4', 'FZD9', 'FAS', 'NRG1', 'HSPA2', 'ATP5F1E']",0.9999339763753385,0,0,7
386,DNA IR-damage and cellular response via ATR WP4016,0.8050901622626415,0.7338589490889861,0.15910135770885162,"['BARD1', 'BCL6', 'CHEK2', 'FANCA', 'PML']",0.9999339763753385,0,0,5
387,Cytosolic DNA-sensing pathway WP4655,0.8073079149533687,0.6889289334384503,0.14746532666173257,"['RNF125', 'IL18', 'IRF7']",0.9999339763753385,0,0,3
388,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8073079149533687,0.6889289334384503,0.14746532666173257,"['ADCY2', 'BANF1', 'SYNE2']",0.9999339763753385,0,0,3
389,Pancreatic adenocarcinoma pathway WP4263,0.8076861296797655,0.745964783565664,0.15932446338658615,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'VEGFA']",0.9999339763753385,0,0,6
390,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8160333580043193,0.5973684210526315,0.12144502684952214,['MKNK2'],0.9999339763753385,0,0,1
391,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8160333580043193,0.5973684210526315,0.12144502684952214,['PLA2G5'],0.9999339763753385,0,0,1
392,Nanomaterial induced apoptosis WP2507,0.8160333580043193,0.5973684210526315,0.12144502684952214,['FAS'],0.9999339763753385,0,0,1
393,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8160333580043193,0.5973684210526315,0.12144502684952214,['BCL2L14'],0.9999339763753385,0,0,1
394,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8160333580043193,0.5973684210526315,0.12144502684952214,['PIK3CD'],0.9999339763753385,0,0,1
395,Transcription co-factors SKI and SKIL protein partners WP4533,0.8160333580043193,0.5973684210526315,0.12144502684952214,['TEAD3'],0.9999339763753385,0,0,1
396,Triacylglyceride synthesis WP325,0.8160333580043193,0.5973684210526315,0.12144502684952214,['MOGAT1'],0.9999339763753385,0,0,1
397,"GPCRs, Other WP117",0.8182162696469119,0.6398265231476643,0.1283674925454369,"['EDNRA', 'GNRHR']",0.9999339763753385,0,0,2
398,Mesodermal commitment pathway WP2857,0.8316869212164715,0.7455914768552535,0.13741191688139726,"['SMAD1', 'FZD5', 'ZIC2', 'TRIM5', 'SESN1', 'ARID5B', 'HMGA2', 'TBX6']",0.9999339763753385,0,0,8
399,Gastric Cancer Network 1 WP2361,0.8345162742150977,0.5599872076023392,0.10130338503270409,['GATD3A'],0.9999339763753385,0,0,1
400,Proteoglycan biosynthesis WP4784,0.8345162742150977,0.5599872076023392,0.10130338503270409,['XYLT1'],0.9999339763753385,0,0,1
401,Gastrin signaling pathway WP4659,0.8369040332664387,0.7283150633473346,0.12967348956975813,"['CDKN1A', 'ANXA2', 'IRS1', 'PRKCQ', 'FOS', 'CD44', 'VEGFA']",0.9999339763753385,0,0,7
402,Ectoderm Differentiation WP2858,0.8423261661202444,0.7454044117647058,0.12790242914257732,"['FZD5', 'BOC', 'PIM1', 'HESX1', 'RHPN1', 'CCL2', 'TNFRSF11B', 'KIFC3', 'ARHGAP15']",0.9999339763753385,0,0,9
403,Amyotrophic lateral sclerosis (ALS) WP2447,0.8453715528028277,0.5970738844184346,0.1002958983967073,"['CST3', 'TNFRSF1A']",0.9999339763753385,0,0,2
404,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8453715528028277,0.5970738844184346,0.1002958983967073,"['GABRA2', 'BDNF']",0.9999339763753385,0,0,2
405,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8453715528028277,0.5970738844184346,0.1002958983967073,"['TSPO', 'GRIN2D']",0.9999339763753385,0,0,2
406,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.8511434331024029,0.5270037839697282,0.08493963360530636,['ETV6'],0.9999339763753385,0,0,1
407,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8511434331024029,0.5270037839697282,0.08493963360530636,['MRAS'],0.9999339763753385,0,0,1
408,Nucleotide metabolism WP404,0.8511434331024029,0.5270037839697282,0.08493963360530636,['SAT1'],0.9999339763753385,0,0,1
409,Purinergic signaling WP4900,0.8511434331024029,0.5270037839697282,0.08493963360530636,['P2RY12'],0.9999339763753385,0,0,1
410,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8511434331024029,0.5270037839697282,0.08493963360530636,['HTR2B'],0.9999339763753385,0,0,1
411,Ras signaling WP4223,0.8552935176472353,0.7507785360150199,0.11735462350893255,"['MRAS', 'PLCG2', 'GAB1', 'PLCE1', 'PIK3CD', 'PLA2G5', 'ETS1', 'FGFR3', 'IGF1R', 'EPHA2', 'ARF6']",0.9999339763753385,0,0,11
412,Apoptosis WP254,0.8562013679363875,0.650975690975691,0.1010637726522247,"['IRF7', 'FAS', 'IGF1R', 'TNFRSF1A']",0.9999339763753385,0,0,4
413,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8562013679363875,0.650975690975691,0.1010637726522247,"['PAX8', 'ADCY2', 'FOS', 'IGF1R']",0.9999339763753385,0,0,4
414,Disruption of postsynaptic signaling by CNV WP4875,0.8575191230600971,0.577766241121363,0.08880948846635416,"['RYR2', 'GRIN2D']",0.9999339763753385,0,0,2
415,Parkinson's disease pathway WP2371,0.8575191230600971,0.577766241121363,0.08880948846635416,"['GPR37', 'CCNE2']",0.9999339763753385,0,0,2
416,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8637595571301588,0.6103919872221483,0.08939852273018886,"['DDX3Y', 'RNF125', 'IRF7']",0.9999339763753385,0,0,3
417,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8637595571301588,0.6103919872221483,0.08939852273018886,"['BDNF', 'PIK3CD', 'GRIN2D']",0.9999339763753385,0,0,3
418,1q21.1 copy number variation syndrome WP4905,0.8661010369875717,0.4976851851851852,0.07154408996032172,['GJA1'],0.9999339763753385,0,0,1
419,Kallmann's Syndrome WP5074,0.8661010369875717,0.4976851851851852,0.07154408996032172,['PRKCQ'],0.9999339763753385,0,0,1
420,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8661010369875717,0.4976851851851852,0.07154408996032172,['CHEK2'],0.9999339763753385,0,0,1
421,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8661010369875717,0.4976851851851852,0.07154408996032172,['NFATC2'],0.9999339763753385,0,0,1
422,Prader-Willi and Angelman Syndrome WP3998,0.8687879688534933,0.5596653255303584,0.07872038559398184,"['BDNF', 'GHRL']",0.9999339763753385,0,0,2
423,Pathways in clear cell renal cell carcinoma WP4018,0.876482791662582,0.6483488461048068,0.08547714991801449,"['SLC2A1', 'ENPP3', 'HK2', 'PFKP', 'VEGFA']",0.9999339763753385,0,0,5
424,Pathways Regulating Hippo Signaling WP4540,0.876482791662582,0.6483488461048068,0.08547714991801449,"['PRKCQ', 'FGFR3', 'IGF1R', 'EPHA2', 'TEAD3']",0.9999339763753385,0,0,5
425,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8792319697278335,0.5426614351266875,0.06984406173903498,"['ACTA2', 'TEAD3']",0.9999339763753385,0,0,2
426,Fatty Acid Biosynthesis WP357,0.879556617555399,0.4714527546937519,0.060504993495561515,['ACSL6'],0.9999339763753385,0,0,1
427,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.879556617555399,0.4714527546937519,0.060504993495561515,['BDNF'],0.9999339763753385,0,0,1
428,Glycerolipids and Glycerophospholipids WP4722,0.879556617555399,0.4714527546937519,0.060504993495561515,['PNPLA3'],0.9999339763753385,0,0,1
429,IL-7 signaling pathway WP205,0.879556617555399,0.4714527546937519,0.060504993495561515,['IL7'],0.9999339763753385,0,0,1
430,Signal Transduction of S1P Receptor WP26,0.879556617555399,0.4714527546937519,0.060504993495561515,['S1PR3'],0.9999339763753385,0,0,1
431,Sphingolipid Metabolism (general overview) WP4725,0.8916609064698441,0.447843567251462,0.051353938987453905,['UGCG'],0.9999339763753385,0,0,1
432,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8958527471468225,0.5964835164835165,0.06560079440018099,"['CDKN1A', 'GADD45B', 'GADD45A', 'FOS']",0.9999339763753385,0,0,4
433,DNA Mismatch Repair WP531,0.9025495190934794,0.4264828738512949,0.04372802323715631,['RPA3'],0.9999339763753385,0,0,1
434,Estrogen signaling pathway WP712,0.9025495190934794,0.4264828738512949,0.04372802323715631,['FOS'],0.9999339763753385,0,0,1
435,Fluoropyrimidine Activity WP1601,0.9025495190934794,0.4264828738512949,0.04372802323715631,['XRCC3'],0.9999339763753385,0,0,1
436,Sphingolipid Metabolism (integrated pathway) WP4726,0.9025495190934794,0.4264828738512949,0.04372802323715631,['UGCG'],0.9999339763753385,0,0,1
437,G Protein Signaling Pathways WP35,0.9087261014456405,0.6042938099389712,0.057837896450421596,"['GNA14', 'AKAP10', 'PRKCQ', 'ADCY2', 'PDE8B']",0.9999339763753385,0,0,5
438,Acute viral myocarditis WP4298,0.9118871559791728,0.5368814055636896,0.04952141956004794,"['LAMA2', 'CXCR4', 'NFKB2']",0.9999339763753385,0,0,3
439,AGE/RAGE pathway WP2324,0.9118871559791728,0.5368814055636896,0.04952141956004794,"['LGALS3', 'IRS1', 'MYD88']",0.9999339763753385,0,0,3
440,Photodynamic therapy-induced unfolded protein response WP3613,0.9123444695042211,0.40706406166932485,0.03734310140686483,['HSPA5'],0.9999339763753385,0,0,1
441,Physiological and pathological hypertrophy of the heart WP1528,0.9123444695042211,0.40706406166932485,0.03734310140686483,['FOS'],0.9999339763753385,0,0,1
442,Metabolic reprogramming in colon cancer WP4290,0.9137658331171273,0.4838371656220961,0.043632890617321576,"['SLC2A1', 'PYCR1']",0.9999339763753385,0,0,2
443,Hippo-Merlin Signaling Dysregulation WP4541,0.9142103128586625,0.5961876832844575,0.0534748350944346,"['FGFR3', 'CD44', 'IGF1R', 'EPHA2', 'TEAD3']",0.9999339763753385,0,0,5
444,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9182114815204296,0.5263112565670485,0.04490884630589653,"['ANGPT2', 'TNIP2', 'ANGPTL1']",0.9999339763753385,0,0,3
445,EGF/EGFR signaling pathway WP437,0.9186852082424517,0.671657067613847,0.056964413038905766,"['GJA1', 'PLSCR1', 'EGF', 'INPP5D', 'LIMK2', 'NEDD4', 'GAB1', 'PLCE1', 'FOS', 'ARF6']",0.9999339763753385,0,0,10
446,Interleukin-11 Signaling Pathway WP2332,0.9208210668766889,0.47106610711123087,0.03885802787571465,"['SOCS3', 'ICAM1']",0.9999339763753385,0,0,2
447,Glycerophospholipid Biosynthetic Pathway WP2533,0.9211555334693535,0.38933384185100434,0.03197457998684025,['PIK3CD'],0.9999339763753385,0,0,1
448,Sphingolipid pathway WP1422,0.9211555334693535,0.38933384185100434,0.03197457998684025,['UGCG'],0.9999339763753385,0,0,1
449,Ciliopathies WP4803,0.9224214370072616,0.6775074907318064,0.05471080970927833,"['NEK8', 'DNAH11', 'ZIC2', 'MAK', 'DNAH6', 'SCLT1', 'UNC119', 'IFT27', 'PKD1L1', 'CCDC151', 'GLI2']",0.9999339763753385,0,0,11
450,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9255518726565027,0.5503747534516765,0.04257979799677822,"['SLCO1C1', 'PAX8', 'DIO2', 'PRKCQ']",0.9999339763753385,0,0,4
451,ATM Signaling Network in Development and Disease  WP3878,0.9273299702803212,0.45894997467784593,0.03462585798551133,"['CHEK2', 'HSPB1']",0.9999339763753385,0,0,2
452,Histone Modifications WP2369,0.9273299702803212,0.45894997467784593,0.03462585798551133,"['SETBP1', 'HIST1H4H']",0.9999339763753385,0,0,2
453,Glycosylation and related congenital defects WP4521,0.9290814754795071,0.3730811403508772,0.027443416532329498,['MGAT2'],0.9999339763753385,0,0,1
454,Pathways affected in adenoid cystic carcinoma WP3651,0.9296327394320179,0.5063675792148954,0.036947452046621684,"['CHEK2', 'ERBIN', 'ARID5B']",0.9999339763753385,0,0,3
455,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9333310465869086,0.4474396488661302,0.030871242459106298,"['PIM1', 'PDCD4']",0.9999339763753385,0,0,2
456,Joubert Syndrome WP4656,0.9351233913349153,0.5338581816193757,0.03580949263562778,"['NEK8', 'FLNA', 'UNC119', 'PDE6B']",0.9999339763753385,0,0,4
457,GABA receptor Signaling WP4159,0.9362111524356745,0.35812865497076024,0.023605777304223453,['GABRA2'],0.9999339763753385,0,0,1
458,Nanoparticle-mediated activation of receptor signaling WP2643,0.9362111524356745,0.35812865497076024,0.023605777304223453,['PIK3CD'],0.9999339763753385,0,0,1
459,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9388605796570032,0.4364908023623031,0.02753745756503242,"['HSPA5', 'PPP1R3C']",0.9999339763753385,0,0,2
460,Cytoplasmic Ribosomal Proteins WP477,0.9414066545425496,0.551754100141197,0.033314957406176085,"['RPL32', 'RPL26', 'RPL9', 'RPS21', 'RPS12']",0.9999339763753385,0,0,5
461,Intraflagellar transport proteins binding to dynein WP4532,0.9426245066093467,0.3443263607737292,0.02034530322903041,['IFT27'],0.9999339763753385,0,0,1
462,Lipid Metabolism Pathway WP3965,0.9426245066093467,0.3443263607737292,0.02034530322903041,['HILPDA'],0.9999339763753385,0,0,1
463,Melatonin metabolism and effects WP3298,0.9426245066093467,0.3443263607737292,0.02034530322903041,['APOE'],0.9999339763753385,0,0,1
464,Proteasome Degradation WP183,0.9440363971688926,0.4791230914034721,0.027592965828590298,"['NEDD4', 'UBC', 'PSMB9']",0.9999339763753385,0,0,3
465,Nuclear receptors WP170,0.9483934598759339,0.3315464587394412,0.017567261239705062,['ESRRB'],0.9999339763753385,0,0,1
466,Wnt Signaling Pathway WP363,0.9486394096521384,0.4161208553784386,0.021940605158200892,"['GJA1', 'NFATC2']",0.9999339763753385,0,0,2
467,PDGFR-beta pathway WP3972,0.9535827173338314,0.3196794068504595,0.015194076553769817,['FOS'],0.9999339763753385,0,0,1
468,Nonalcoholic fatty liver disease WP4396,0.9563050946463431,0.5854422375061732,0.026156552319230898,"['SOCS3', 'IRS1', 'PIK3CD', 'CCL2', 'FAS', 'IRS2', 'COX7A1', 'TNFRSF1A']",0.9999339763753385,0,0,8
469,Fatty acid beta-oxidation WP143,0.9582504915582603,0.3086307723331317,0.013161886973831652,['ACSL6'],0.9999339763753385,0,0,1
470,miRNA regulation of prostate cancer signaling pathways WP3981,0.9582504915582603,0.3086307723331317,0.013161886973831652,['CDKN1A'],0.9999339763753385,0,0,1
471,Rett syndrome causing genes WP4312,0.9605577181950176,0.3888871219108807,0.01564928707794299,"['HAP1', 'SYNE2']",0.9999339763753385,0,0,2
472,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9624491531851805,0.29831871345029237,0.011417862990413327,['NFATC2'],0.9999339763753385,0,0,1
473,Tumor suppressor activity of SMARCB1 WP4204,0.9624491531851805,0.29831871345029237,0.011417862990413327,['GLI2'],0.9999339763753385,0,0,1
474,Androgen receptor signaling pathway WP138,0.963218757945059,0.4766007326007326,0.01786048377510029,"['CDKN1A', 'PRDX1', 'LIMK2', 'FLNA']",0.9999339763753385,0,0,4
475,IL-5 signaling pathway WP127,0.9662258167727256,0.2886719486889266,0.009918106322605005,['FOS'],0.9999339763753385,0,0,1
476,p38 MAPK Signaling Pathway WP400,0.9662258167727256,0.2886719486889266,0.009918106322605005,['HSPB1'],0.9999339763753385,0,0,1
477,16p11.2 proximal deletion syndrome WP4949,0.9676690988938338,0.4256431708847521,0.013988801175144642,"['MVP', 'TBX6', 'CCT6B']",0.9999339763753385,0,0,3
478,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9696228683842183,0.2796281067251462,0.008625989805366647,['NFKB2'],0.9999339763753385,0,0,1
479,Leptin signaling pathway WP2034,0.9701507374256777,0.41895818081991215,0.012696033361950625,"['SOCS3', 'IRS1', 'PLCG2']",0.9999339763753385,0,0,3
480,Target Of Rapamycin (TOR) Signaling WP1471,0.9726784393751512,0.2711323763955343,0.007510837268545886,['DDIT4L'],0.9999339763753385,0,0,1
481,PDGF Pathway WP2526,0.9778989108879457,0.2555973266499582,0.005712338874222162,['FOS'],0.9999339763753385,0,0,1
482,3q29 copy number variation syndrome WP4906,0.978923418547999,0.3373314377993402,0.007185788299823552,"['PIGM', 'SLC51A']",0.9999339763753385,0,0,2
483,Common Pathways Underlying Drug Addiction WP2636,0.9821223745769997,0.24174174174174173,0.004360866474629177,['GRIA4'],0.9999339763753385,0,0,1
484,Chemokine signaling pathway WP3929,0.9828374998687854,0.4507686839065138,0.007803474367087422,"['GRK5', 'WAS', 'PIK3CD', 'CXCR4', 'ADCY2']",0.9999339763753385,0,0,5
485,Pyrimidine metabolism WP4022,0.9830888439727915,0.3774359185861877,0.0064374649270770665,"['ENTPD3', 'ENPP3', 'DHODH']",0.9999339763753385,0,0,3
486,Splicing factor NOVA regulated synaptic proteins WP4148,0.9839212018225402,0.23536088027085256,0.0038150738534570247,['AGRN'],0.9999339763753385,0,0,1
487,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9869943264767894,0.2235562865497076,0.0029265726233327002,['MSMO1'],0.9999339763753385,0,0,1
488,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9894803370317583,0.21287593984962405,0.002251245182339314,['CP'],0.9999339763753385,0,0,1
489,Nucleotide Excision Repair WP4753,0.9905390931617166,0.20790833673330614,0.0019763653208156227,['RPA3'],0.9999339763753385,0,0,1
490,DNA IR-double strand breaks and cellular response via ATM WP3959,0.993118022737235,0.19430142384947877,0.0013418004151508718,['CHEK2'],0.9999339763753385,0,0,1
491,Oxidative phosphorylation WP623,0.9949941324642947,0.1823606635636711,0.0009151658408808277,['ATP5F1E'],0.9999339763753385,0,0,1
492,Integrin-mediated Cell Adhesion WP185,0.9977324093172735,0.23173315345956166,0.000526072624030727,"['CAPN9', 'SELENOP']",0.9999339763753385,0,0,2
493,Endoderm differentiation WP2853,0.9979938609990604,0.2785733894582723,0.0005594182644229276,"['TRIM5', 'SESN1', 'GLI2']",0.9999339763753385,0,0,3
494,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9988356187088059,0.21230013585536628,0.0002473423346629675,"['COX7A1', 'ATP5F1E']",0.9999339763753385,0,0,2
495,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9989803077793437,0.1394485562865497,0.00014226715471602099,['DBI'],0.9999339763753385,0,0,1
496,Thermogenesis WP4321,0.9993447725776368,0.19804925627895636,0.00012980983582039504,"['ACSL6', 'ADCY2']",0.9999339763753385,0,0,2
497,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9993638224359481,0.2825047967905111,0.0001797804056507749,"['IRS1', 'BDNF', 'IRS2', 'FOS']",0.9999339763753385,0,0,4
498,Ciliary landscape WP4352,0.9996768921489586,0.36218866679662315,0.00011704491188362354,"['NEK8', 'WHRN', 'CDH23', 'USH1C', 'IFT27', 'STOM', 'VIM', 'MAPRE2']",0.9999339763753385,0,0,8
499,Genes related to primary cilium development (based on CRISPR) WP4536,0.999696465717642,0.18176253676305928,5.517953602009097e-05,"['SCLT1', 'IFT27']",0.9999339763753385,0,0,2
500,DNA Repair Pathways Full Network WP4946,0.9998836630901378,0.16479720393399983,1.917311275158898e-05,"['RPA3', 'FANCA']",0.9999339763753385,0,0,2
501,Fragile X Syndrome  WP4549,0.9999339763753385,0.1560466638432218,1.0303106491218614e-05,"['BDNF', 'GAB1']",0.9999339763753385,0,0,2
